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Enforced expression of Tbx1 in fetal thymic epithelial cells  
antagonizes thymus organogenesis 
Kim T. Cardenas 
 
The thymus and parathyroid glands originate from organ-specific domains of 
3rd pharyngeal pouch (PP) endoderm. At embryonic day 11.5 (E11.5), the 
ventral thymus and dorsal parathyroid domains can be identified by Foxn1 and 
Gcm2 expression respectively. Neural crest cells, (NCCs) play a role in 
regulating patterning of 3rd PP endoderm. In addition, pharyngeal endoderm 
influences fate determination via secretion of Sonic hedgehog (Shh), a 
morphogen required for Gcm2 expression and generation of the parathyroid 
domain. Gcm2 is a downstream target of the transcription factor Tbx1, which in 
turn is positively regulated by Shh. Although initially expressed throughout 
pharyngeal pouch endoderm, Tbx1 expression is excluded from the thymus-
specific domain of the 3rd PP by E10.5, but persists in the parathyroid domain. 
Based on these observations, we hypothesized that Tbx1 expression is non-
permissive for thymus fate specification and that enforced expression of Tbx1 in 
the fetal thymus would impair thymus development. 
To test this hypothesis, we generated knock-in mice containing a Cre-
inducible allele that allows for tissue-specific Tbx1 expression. Expression of the 
R26iTbx1 allele in fetal and adult thymus using Foxn1Cre resulted in severe thymus 
hypoplasia throughout ontogeny that persisted in the adult. Thymic epithelial cell 
	   vii	  
(TEC) development was impaired as determined by immunohistochemical and 
FACS analysis of various differentiation markers. The relative level of Foxn1 
expression in fetal TECs was significantly reduced. TECs in R26iTbx1/+ thymi 
assumed an almost universal expression of Plet-1, a marker associated with a 
TEC stem/progenitor cell fate. In addition, embryonic R26iTbx1/+ mice develop a 
perithymic mesechymal capsule that appears expanded compared to control 
littermates. Interestingly, thymi from neonatal and adult R26iTbx1/+ but not R26+/+ 
mice were encased in adipose tissue. This thymic phenotype also correlated with 
a decrease in thymocyte cellularity and aberrant thymocyte differentiation. The 
results to date support the conclusion that enforced expression of Tbx1 in TECs 
antagonizes their differentiation and prevents normal organogenesis via both 
direct and indirect effects.  	  
	  	   viii	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Introduction 
 
Overview of thymus composition, organization and involution 
The thymus plays a critical role in the development of a competent immune 
response. It is required for the generation of T-cells with a vast T-cell receptor 
(TCR) repertoire and thus the generation of a functional immune system. The 
cellular composition of the thymus is made up largely of developing thymocytes; 
however, thymic stromal cells, of which thymic epithelial cells, (TECs), are an 
essential component, play an indispensible role in thymocyte development. The 
thymus is organized into two main regions that can be identified based on their 
histological appearance in tissue sections stained with hematoxylin and eosin 
(H&E). The outer dark staining region is the thymic cortex and contains the most 
immature thymocytes. Inner lighter staining areas are referred to collectively as the 
thymic medulla and contain fewer but more mature thymocytes. Each region not 
only contains different thymocyte subsets, but also different TEC subsets that are 
specialized in supporting specific stages of thymocyte maturation. Differentiation, 
proliferation and survival of both cell types in an interdependent process, referred to 
as crosstalk, that relies upon reciprocal signaling events between different cell 
types. 
TECs form a three-dimensional meshwork that facilitates thymocyte migration 
into different microenvironmental zones of the cortex and medulla. In addition, they 
also provide essential signals to developing thymocytes required for their survival, 
proliferation and maturation. Each region within the thymus contains phenotypically 
	  	   2	  
and functionally distinct TECs. Cortical TECS (cTECs) express cytokines and 
chemokines that support the earliest stages of thymocyte development and 
medullary TECs (mTECs) play a role in later stages of T-cell development. The 
details of these dynamic processes will be elaborated upon in a later section.  
The thymus is largest in preadolescent individuals and undergoes progressive 
age-related thymic atrophy referred to as thymic involution that is initiated around 
the onset of puberty and is associated with a decline in naïve T-cell output. While 
the molecular mechanisms responsible for thymus involution are not known, it is 
correlated with a failure in TEC homeostasis and the ability to support thymopoiesis. 
The consequences of thymus involution are critical to human health and disease. 
Decreased T-cell output results in a deficiency of naïve T-cells and homeostatic 
expansion of memory T-cells in peripheral lymphoid organs. Therefore, there are 
fewer naïve T-cells available to respond to new antigenic challenges. Older 
individuals are more susceptible to infectious disease, autoimmunity and cancer. 
This is likely due in part to the diminished ability to mount an effective T-cell 
response to newly encountered antigens. Reversing thymic involution and/or 
sustaining thymic function would allow for a lasting competent immune response 
and the ability to efficiently combat a wide array of pathogens and disease. My work 
is aimed at understanding the molecular events required to generate a functional 
thymus in order to devise future therapeutic strategies targeted at its regeneration 
or maintenance. 
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Lymphoid Cells Within the Thymus  
B-cells develop and mature in the bone marrow while T-cell progenitors migrate 
to the thymus where they continue maturation. There are two classes of T cells 
distinguished by the nature of their TCRs. The majority of T-cells in the adult are of 
the αβ lineage (reviewed in(1)). These T cells express αβ TCRs consisting of a 
TCR-α chain and a TCR-β chain linked by a disulfide bond to form an α:β 
heterodimer. Mature αβ T-cells circulate through the peripheral lymph nodes and 
spleen. A small subset of γδ T cells found mainly in skin and at mucosal surfaces 
expresses γδ TCRs consisting of a TCRγ:TCRδ heterodimer. Rearrangement of 
TCR-γ, -δ and -β loci occurs in a simultaneous fashion. However if a successful γδ 
TCR is generated prior to the rearrangement of the β chain gene, signaling through 
the newly generated γδ TCR will result in cessation of further gene rearrangements 
and commitment to the γδ linage.  If instead complete β-chain rearrangement occurs 
first, pairing of this β-chain with a pre-T-cell α chain will result in formation of a pre-
TCR through which signaling will occur and result in commitment to the αβ lineage 
(reviewed in (1), (2)). Since the majority of T-cells generated in the adult are αβ T-
cells, for the remainder of this dissertation T-cells will refer only to those of this 
lineage. 
Both α- and β- chains of the TCR, consist of a variable (V) region and a 
constant (C) region. Two short stalk segments interconnect the chains and also 
anchor them to the membrane. Both chains span the lipid-bilayer and end in short 
cytoplasmic tails. There are two main types of mature T-cells that arise from the αβ-
lineage, namely, CD4+ and CD8+. Mature CD4+ T-cells are negative for CD8 and 
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recognize antigenic peptides presented by self- MHC class II molecules, while CD8+ 
T-cells are negative for CD4 and recognize peptides presented by self-MHC class I. 
These T cell subsets also differ in effector and regulatory functions. CD4+ T-cells 
differentiate into specialized T helper (TH) cells that secrete various cytokines that 
activate B-cells or cells of the innate immune system, (reviewed in (3)) For example, 
TH1 cells produce cytokines such as IL-2 and IFNγ that activate inflammatory cells 
to destroy intracellular pathogens (reviewed in (3)). TH2 cells produce IL-4 and other 
cytokines that promote antibody production by B-cells.  TH17 cells produce IL-17, a 
potent pro-inflammatory cytokine. TH cells also promote the differentiation of CD8+ 
T-cells into cytotoxic effector cells. T regulatory (Treg) cells are another class of T-
cells that develop in the thymus and play an essential role in suppressing T-cell 
responses. 
 
Thymocyte Development   
Common lymphoid progenitors in the bone marrow are the source of thymus 
seeding lymphoid cells (4). After entry into the adult thymus through the 
vasculature, at the corticomedullary junction (CMJ), thymocyte progenitors undergo 
a progressive differentiation process that depends on continual interactions with 
TECs in the thymic microenvironment (reviewed in (5), (6)).  Different thymocyte 
maturation stages can be recognized by the expression pattern of key cell surface 
markers and distinct thymocyte phenotypes that correlate with passage through 
developmental checkpoints required for the eventual production of self-tolerant and 
self-restricted T-cells.   
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The earliest thymocyte progenitors are double negative (DN) for CD4 and CD8 
(2). DN thymocytes gradually become committed to a T-cell lineage as they proceed 
through distinct differentiation stages (DN1-DN4) defined by the expression patterns 
of CD44 or c-kit and CD25 (2). DN1 thymocytes (CD44+ CD25-) retain the capability 
to develop into natural killer cells, dendritic cells and retain some myeloid 
differentiation potential (7). Activation of Notch receptors on DN2 (CD44+ CD25+) 
and DN3 (CD44- CD25+) thymocytes by Delta like 4 (Dll4) ligand expressed on 
TECs is necessary but not sufficient for T lineage commitment (reviewed in (8)). 
Rearrangement of the TCRβ locus begins at the DN2 stage (2). DN3 thymocytes 
with productive TCRβ gene rearrangements express a TCRβ polypeptide that pairs 
with the monomorphic pre-Tα polypeptide to generate a pre-TCR (reviewed in (9)). 
Signaling through the pre-TCR allows DN3 cells to survive and differentiate to the 
DN4 (CD44- CD25-) stage. The DN3 to DN4 transition is referred to as the β-
selection checkpoint and is required for continued thymocyte maturation (reviewed 
in(9)). The DN4 stage coincides with a proliferative burst, as the CD4 and CD8 co-
receptors are up-regulated yielding CD4+ CD8+ double positive (DP) thymocytes 
(reviewed in (10)). Tcrα gene rearrangement then proceeds resulting in one of two 
possible fates: positive selection or cell death by neglect (reviewed in (9)). DP 
thymocytes expressing αβ TCRs with moderate affinity for self-peptide-MHC 
complexes presented on cortical TECs, are rescued from programmed cells death 
(reviewed in (9)). Positively selected DP thymocytes down-regulate either CD4 or 
CD8 to produce single positive (SP) semi-mature thymocytes that migrate into the 
medulla.   
	  	   6	  
The exact mechanisms that determine CD4 versus CD8 lineage commitment 
are not clear. Classical models predict lineage commitment to be either a stochastic 
or directed consequence of TCR-signaled DP thymocytes resulting in transcriptional 
silencing of either the CD4 or CD8 co-receptor (1). However work by Al Singer’s 
group proposes a different model in which lineage commitment is dependent on 
persistence or cessation of a TCR-signal during positive selection (1). The kinetic 
signaling model postulates that positively selected DP thymocytes proceed through 
a CD4+CD8- intermediate that retains the capability to differentiate into either a CD4 
or CD8 SP thymocyte (1). The determining factor is the persistence of the TCR 
signal itself. If a CD4+CD8- intermediate thymocyte receives a sustained TCR 
signal then the developing thymocyte will proceed to develop into a CD4 SP 
thymocyte (1). However if this intermediate does not receive this persistent signal 
then a process called “co-receptor reversal” will be initiated and the thymocyte will 
adopt a CD8 SP fate (1). 
The cytokine IL-7 is secreted by the thymic epithelium to developing 
thymocytes and is required for their survival and proliferation (reviewed in (11), 
(12)). Early studies by Ursula von Freeden-Jeffry, demonstrate DN2 thymocytes 
lacking IL-7 are impaired in cell-cycle regulation and expression of the pro-survival 
molecule Bcl-2 (13). IL-7 is expressed early in ontogeny throughout the developing 
epithelium its expression is dependent on thymocyte derived signals (12, 14). 
Auto-reactive SP thymocytes are eliminated in the medulla by a process 
referred to as negative selection (reviewed in (15)). Medullary TECs have the 
unique ability to express a vast array of tissue-restricted antigens (TRAs) (reviewed 
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in (15)). In addition to directly presenting TRAs to SP thymocytes, mTECs can 
transfer TRAs for cross-presentation by dendritic cells. SP thymocytes that express 
 αβ TCRs with high affinity for self-antigens presented by mTECs and/or dendritic 
cells undergo apoptosis. Only those T-cells that are self-tolerant and able to 
recognize antigen in the context of the self-MHC molecules will gain entry into the 
periphery.  
While millions of thymocytes proliferate and differentiate within the thymus, the 
vast majority, (~98%), undergo apoptosis at some point along their developmental 
journey. Only 2-4% of incoming thymocytes will fulfill all of the maturational 
requirements to become naïve T cells and gain access to the periphery where they 
undergo further maturation to become fully competent and exert an effector 
function. This intense, selective screening allows for the formation of a diverse T-
cell repertoire capable of responding to a vast array of pathogens while maintaining 
self-tolerance. The entire thymocyte maturational process is guided and shaped by 
the thymic epithelium, which plays an indispensible role in the formation of a 
functional T-cell repertoire.  
 
Thymic Epithelial Cells 
TECs are the major constituent of the thymic stromal microenvironment and 
play an indispensible role at all stages of thymocyte development (16). They provide 
essential growth, survival and differentiation signals for the generation of naïve T-
cells (reviewed in (17)) . Evidence for the importance of TECs in thymocyte 
maturation is provided by examination of athymic nude mice, which harbor an 
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inactivating point mutation in the coding region of Foxn1, a transcription factor 
required for TEC differentiation and survival ((18), reviewed in (19)). Thymic 
development in this model is severely impaired beyond embryonic day E11.5 in 
mouse gestation (E11.5) resulting in an essentially athymic phenotype. Despite 
competent thymus seeding progenitors in the bone marrow, the early block in TEC 
differentiation not only prevents expression of chemokines that attract thymocyte 
progenitors, but also prevents expression of cytokines required to support 
thymocyte survival (reviewed in (20)). Therefore, nude mice are devoid of 
essentially all T-cells because thymocyte maturation cannot occur in the absence of 
functional TECs. The roles of Foxn1 in thymus organogenesis, maintenance and 
homeostasis will be discussed in greater detail during the organogenesis portion of 
this dissertation. 
In the adult, TEC subsets can be defined on the basis of morphology, function 
and phenotype. Each subset varies in the types of intermediate keratin filaments 
expressed. cTECs express high levels of keratin 8 (K8) and are negative for keratin 
5 expression (K5) (reviewed in (17)). Several non-overlapping mTEC subsets exist. 
One subset of mTECs expresses low levels of K8 and high levels of K5 and K14 
while another distinct subset expresses high levels of K8 and binds the lectin UEA-1 
but is negative for K5 and K14.TECs that reside at the CMJ co-express both K8 and 
K5, (K8+K5+) (reviewed in (17)). During thymus organogenesis, the expression of 
keratins and other differentiation markers is dynamic and the phenotype of cTECs 
and mTECs corresponds to their differentiation stage (reviewed in (17)) . Studies by 
Klug et. al., have demonstrated the E11.5 thymic primordia consists largely of K5-
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K8+ TECs, which begin to up-regulate K5 expression at E12.5 (21). The majority of 
cells within the thymus at E12.5 are epithelial and express the marker EpCAM1 
(22). At this time in development a central core of K5+K8+ TECs is present 
surrounded by K8+K5- TECs (21). TEC progenitors also express MTS24. Isolated 
MTS24+ cells have shown to retain the capability to reconstitute the TEC 
microenvironmental compartment when grafted under the kidney capsule of a nude 
host, suggesting that a common MTS24 progenitor may give rise to differentiated 
cTEC and mTEC populations (23). MHC class II (MHC II) molecules are expressed 
on TECs after E12.5 (24). While the exact time at which commitment to a cTEC or 
mTEC lineages is not known, work by the Jenkinson lab suggests that the 
expression of CD205 is associated with adoption of a cortical fate (22). Later stages 
of cTEC maturation include expression of the proteosome-specific subunit  β5t and 
Cathepsin-L (5). Expression of both CD205 and β5t are evident as early as E12 with 
the overall percentage of CD205+, β5t+ TECs increasing with age (22, 25) 
Emergence of defined K5+K14+K8lo medullary islets occurs at approximately 
E17.5 (21). During embryogenesis activation of the NFκB signaling pathway by 
lymphoid tissue inducer (Lti) cells is required for initial mTEC development 
(reviewed in (26)). At postnatal stages the requirement of the NFκB pathway for 
mTEC development persists. The mTEC subset expresses several receptors of the 
TNFα family including RANK, CD40 and LTβR (reviewed in (26)). The ligands 
RANKL, CD40L and LTβR are expressed by CD4+ SP thymocytes and activate 
NFκB target genes needed for mTEC maturation. As mTECs undergo maturation, 
they up-regulate expression of MHCII, CD80 and other surface molecules (27). In 
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addition, mTEC differentiation is associated with the expression of the Aire 
transcription factor. Aire is responsible for the expression of many, but not all, of the 
TRAs expressed by mTECs (15).  
In addition to their direct roles in negative and positive selection, TECs also 
provide migrational cues to developing T-cells that aid their navigation through the 
thymic microenvironment. Chemokine ligands such as CCL21 and CCL25 are 
expressed by fetal TECs and support thymus colonization by thymus seeding cells 
(5). Migration of DN thymocytes to the outer subcapsular region, where they 
continue to mature, is a chemokine-guided process whereby TECs signal thru the 
receptor CCR9, expressed on immature T-cells (28). Furthermore, CCL19 and 
CCL21 expressed by mTECs attract positively selected thymocytes into the medulla 
where they are subject to negative selection (28). These chemokines also guide 
self-tolerant mature T-cells out of the thymus and into the periphery (reviewed in 
(26)).  
Thymocyte-derived signals are also essential for organization and maintenance 
of TECs after initial patterning of the fetal thymus. This is evidenced by the hCD3ε 
transgenic mouse model in which thymocyte development is arrested at the DN1 
stage that results in a block in TEC development at the immature K5+K8+ stage (21, 
29).  RAG-1-/- and RAG-2-/- have a block in thymocyte development at the DN3 
stage; whereas TCRα-/- mice generate DP thymocytes that cannot undergo positive 
selection due to the absence of αβ TCR expression (21). Both of these 
experimental models have thymi that contain predominantly cTECs, whereas 
mTECs are sparse and medullary regions are underdeveloped (21, 29). These 
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results further demonstrate that signals derived from positively selected thymocytes 
are required for normal medullary formation. In summary, the intra-thymic crosstalk 
between TECs and thymocytes is mutually required for proper establishment, 
organization and maturation of both cell types.  
 
Contribution of neural crest cells to the embryonic and postnatal thymus 
Epithelial-mesenchymal interactions are a common theme in developmental 
biology and in thymic development contribute to inductive signaling required for 
proper organogenesis. Mesenchyme is a supportive-type of loosely packed, tissue 
that is migratory in nature and contains a fibrous matrix. Mesenchyme is derived 
from two main sources in the embryo, namely the mesoderm or NCCs (30). The 
majority of perithymic mesenchyme is NCC derived and thus termed 
ectomesenchyme. 
NCCs are derived from ectoderm and originate as neurulation proceeds in the 
embryo. During this process signaling between neural and non-neural ectoderm 
occurs which induces NCC precursors to form between the neural folds, dorsal to 
the neural tube (Figure IA and Figure I-B). Delamination from the neural tube occurs 
followed by an epithelial-to-mesenchymal transition yielding a migratory population 
of cells that is developmentally plastic. Ventrolateral migration occurs throughout 
the embryo as NCCs travel to their target destination where they differentiate giving 
rise to various structures such as the peripheral nervous system, facial cartilage, 
pericytes and melanocytes (reviewed in (31)).  
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Figure I.  Neural crest cells arise from the dorsal neural tube and pattern the 
pharyngeal arches. (I-A) Dorsolateral view of embryological day 8 (E8) embryo 
depicting the neural folds and tube. (I-B) Transverse sections of E9 embryo 
showing the neural tube, (depicted by green box). (I-C) E9 embryo showing 
lateral view. Pouches are pointed out with pink arrows. All images are scanning 
electron micrographs used with the permission of the author Dr. Kathy Sulik 
from the University of North Carolina Medical School website: 
(www.med.unc.edu/embryo_images).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I-A I-B
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Perithymic mesenchyme is also NCC-derived as shown by quail-chick 
chimera experiments that used quail NCCs to generate a mesenchymal thymic 
capsule in the recipient chicks (reviewed in(32)). More recent work by Foster et. al. 
used lineage-tracing experiments to analyze the contribution of NCCs to the 
embryonic and adult thymus (33).  NCC-specific Wnt-1Cre and Sox-10Cre mice were 
utilized to indelibly label NCCs and their progeny in a reporter assay (33). Reporter 
mice containing yellow fluorescent protein (YFP) under the control of a ubiquitous 
Rosa26 promoter and downstream of a floxed stop cassette, were crossed to either 
Cre driver and YFP positive cells were analyzed in a fate mapping experiment (33). 
Consistent with previous reports, this study showed that developing thymic lobes 
became encapsulated with NCC-derived mesenchyme by E12.5, further 
emphasizing their role in early thymus development (33, 34). This study also 
demonstrated a novel role for these cells in postnatal development as NC-derived 
cells were found to migrate into the thymic lobes as early as E13.5 and persist 
throughout gestation differentiating into supportive structures of the vasculature 
such as pericytes and cells that express smooth muscle actin protein (33).  
Robert Auerbach first described initial studies demonstrating the importance of 
epitheliomesenchymal interactions in thymus organogenesis in 1960 (35). Although 
the ability to conduct allogeneic or syngenic transplantation experiments was limited 
by the lack of an immunodeficient model, as they preceded discovery of the nude 
mouse, Auerbach performed a series of epithelial-mesenchymal recombination 
experiments which utilized the anterior eye chamber of a mouse host to decipher 
the morphogenic relationship between these two tissues (35). Fetal thymic epithelial 
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lobes striped of mesenchyme remained hypoplastic and round in shape while those 
supplemented with various sources of mesenchyme grew and achieved lobulation 
in vitro to varying degrees depending on the source of supplemented mesenchyme 
(35). Subsequent experiments revealed mesenchymal cells could affect thymus 
growth when physically separated from the thymic epithelium by a thin Millipore filter 
suggesting that the interacting factors were morphogenic and soluble in nature (35).   
Later studies performed by Bockman and Kirby in chick, reiterated the 
requirement for neural crest mesenchyme in thymic development (36). Ablation of 
cephalic regions of NCC prior to migration from the dorsal neural tube resulted in 
hypoplastic thymi that were less developed compared to control thymi (36). This 
study further concluded that NCC-derived mesenchyme differed from somatic 
mesoderm in its ability to support and sustain thymopoiesis. NCC-derived 
mesenchyme could induce thymic epithelial development and proliferation, which 
supported thymocyte maturation, whereas other sources of mesenchyme were less 
effective.  
Studies performed by Jenkinson et. al., analyzed the effects of thymic 
mesenchyme on both thymic epithelial cell differentiation and proliferation (37). 
Thymi from E12 thymic lobes stripped of mesenchyme or epithelial isolates from 
E14 mice were cultured and pulsed with BrdU (37). Compared to intact lobes, 
proliferation of TECs in the stripped lobes decreased three-fold (37). Addition of the 
fibroblast growth factors (FGF) -7 and -10, rescued this proliferative defect. Both 
mitogenic factors were expressed almost exclusively in thymic mesenchyme by 
quantitative RT-PCR (qRT) analysis (37). The common Fgf-7 and Fgf-10 receptor 
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FgfR2-IIIb is expressed on thymic epithelial cells and mediates proliferative signals 
required for expansion and outgrowth of the thymic epithelium (30). This is 
consistent with the hypoplastic thymic phenotype observed in FgfR2-IIIb and Fgf-10 
deficient mice and implicates NCC-derived perithymic mesenchyme as an essential 
source of growth factors required for fetal TEC expansion (38). In addition, some 
investigators reported that NC-derived mesenchyme is required to signal TECs to 
express MHC class II (39). However, another study refuted this claim (37).   
There is some data suggesting that NCC-derived mesenchyme is required for 
thymocyte maturation (40). E12 day thymic lobes cultured in the absence of 
mesenchyme produced significantly less thymocytes (40). Those recovered were 
mostly blocked at the CD4-CD8- stage of development and only very few 
progressed to the SP stage, suggesting mesenchymal-dependent signals are a 
requirement for DN to DP progression (40). Taken together, the current data 
supports the notion that crosstalk between thymocytes, TECS and mesenchyme is 
required mutually, by each cell type, for proper maturation and function. Molecular 
interactions between each cell type occur dynamically throughout organogenesis to 
support normal thymic development.  
Recent studies undertaken in our lab have demonstrated a novel role for NCC 
prior to E12.5 in patterning the common primordia, which will eventually give rise to 
both the parathyroid and thymus (41). These mesenchymal-epithelial interactions 
are critical in early thymus organogenesis but have yet to be fully elucidated. These 
early patterning events are the foundation of this dissertation project. As such they 
will be discussed in greater detail below.  
	  	   17	  
 
Thymus Organogenesis 
Thymus organogenesis can be divided into two distinct phases: 1. Remodeling 
of the pharyngeal endoderm and consequent formation of the pharyngeal pouches 
and 2. Patterning of the shared primordia into their prospective organ domains as 
evidenced by complementary expression patterns of the transcription factors Foxn1 
and Gcm2 (reviewed in (42), (43)). 
The thymus is derived from pharyngeal endoderm (44). During embryogenesis 
five pairs of segmental bulges known as the pharyngeal arches form (45), (Figure I-
C). These arches develop in a cranial to caudal manner during embryogenesis and 
contain components, which will differentiate into specialized structures within the 
body, reviewed in (45). The inner lining of the arch is comprised of endoderm while 
the outer arch is lined by ectoderm. The core of each arch consists of mesoderm 
surrounded by NCC-derived mesenchyme (reviewed in (45)). During development 
the pharyngeal region between each arch, evaginates toward the midline forming an 
epithelial pouch (Figure I-C, depicted by arrows). The external ectoderm proceeds 
to depress in an opposing fashion forming outer pharyngeal clefts. The results of 
these movements facilitate interactions between endoderm, ectoderm and 
mesenchyme necessary for development.  
Previously the thymus was thought to originate from contributions of both 
surface ectoderm and pharyngeal endoderm. This model was coined the “dual-
origin model” and previously widely accepted (44). Studies undertaken by 
investigators have disproved this theory, demonstrating that only third pouch 
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pharyngeal (3rd PP) endoderm gives rise to the thymic epithelium interactions and 
contributions from the surface ectoderm are not required for the generation of a 
functional thymic epithelium (44). For example, studies performed by Gordon et. al. 
utilized ectoderm labeling experiments along with whole-embryo culture techniques 
to trace the contribution of cells derived from an ectodermal lineage (44). They 
found no labeled cells present in the thymic primordium suggesting lack of an 
ectodermal contribution. Furthermore, pharyngeal endoderm isolated from second 
and third pharyngeal pouch at E8.5-E9.0 was able to form both cTEC and mTEC 
subsets when transplanted under the kidney capsules of nude mice (44). The grafts 
contained an organized epithelial architecture and a TEC profile similar to normal 
thymi (44). TEC functionality was also assessed by the ability to support 
thymopoiesis (44). All thymocyte subsets were recovered in percentages 
comparable to wild-type (WT) thymi indicating formation of a functional thymic 
epithelium (44).   
In mouse development the thymus and parathyroid originate from a common 
endodermal primordium arising from the 3rd PP (reviewed in (42)). At E11.5 the cells 
within the pouch are morphologically indistinguishable, however they are already 
fated to become either thymus or parathyroid (PT), (reviewed in (46)). We can 
distinguish these distinct, non-overlapping domains by the expression of the 
transcription factors Foxn1, expressed by the thymus domain and Gcm2, expressed 
by the PT domain, respectively (43). Gcm2 is expressed by 3rd PP endoderm by 
E9.5 and is restricted to the dorsal anterior domain during pouch outgrowth.  The 
adjacent posterior ventral domain expresses Foxn1 by E11.25 (43). Foxn1 and 
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Gcm2 are not required for specification of the 3rd PP but are required for thymus or 
parathryroid development, respectively (47, 48). Foxn1 is expressed in thymic 
endodermal derivatives, and thus all TECs where it is required for their survival and 
differentiation (47, 49). Gcm2 is required for expression of parathyroid-specific 
genes such as CasR, CCL21 and Pth and also for survival of parathyroid progenitor 
cells (48).  
While the exact molecular mechanisms required to establish fate-specification 
are not known, Griffith et. al. demonstrated that NCCs play a role in this process 
(43). Given that NCCs secrete growth factors required for expansion and outgrowth 
of the epithelium, it is not surprising that NCC-deficient models have long been 
reported as having a hypoplastic thymic phenotype. However, studies in our lab 
challenged this central dogma as NCC-deficient Splotch (Pax3Sp/Sp) E12.5 fetal 
thymic lobes were larger than their wild-type counterparts (43). Furthermore, overall 
PT volume was decreased in Pax3Sp/Sp mutants compared to control littermates 
(43). I confirmed this in other NCC-deficient models, specifically Pax3Cre/Cre and 
Tcof+/- mice  (unpublished results).  No significant changes in pouch volume, TEC 
proliferation or apoptosis were observed. Instead, there was a shift in the 
parathyroid-thymus fate-boundary such that the Foxn1 thymus-fated domain was 
expanded and the Gcm2 PT-fated domain was reduced. This result is consistent 
with a previous report linking thymus size to the number of progenitor cells (50). 
Furthermore, it suggests a novel role for NCCs prior to E12 in patterning the 3rd PP 
into their respective organ domains and emphasizes a requirement for migrating 
NCCs to mediate inductive interactions required to sustain parathyroid fate (50).  
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One hypothesis generated from this data predicts that NCCs may directly or 
indirectly influence fate by regulating the expression pattern of key transcription 
factors such as Tbx1, which is thought to act upstream of Gcm2 (48, 51). Whether 
Tbx1 truly serves as a molecular fate switch is a question that still remains to be 
addressed. However, the effects of Tbx1 on thymic development will be discussed 
in greater detail in a subsequent chapter, as the regulatory role of Tbx1 in thymus 
versus PT development is the central question addressed in this dissertation. 
The thymus has not yet undergone vascularization at E11.5; however, early 
hematopoietic progenitors are attracted to the thymus by chemokines secreted from 
the developing pouch (28, 52). The Gcm2-dependent chemokine ligand (CCL) 21 is 
expressed by endoderm in the dorsal parathyroid-fated domain and binds to the 
chemokine receptor (CCR) 7 expressed on lymphoid progenitors (28). In addition, 
CCL25, which is in part regulated by Foxn1, is expressed by both PT and thymus 
domains in E11.5 common primordia and binds the receptor CCR9 (28). These 
ligand-receptor interactions mediate thymic colonization by hematopoietic 
progenitors prior to thymus vascularization.  
At E12.5, NCCs begin to condense around the developing primordia and form a 
mesenchymal capsule around the fetal thymus, (reviewed in (19)). The early 
thymus-parathyroid primordia detaches from the pharyngeal endoderm and by 
E13.5 the thymic rudiments separate from the parathyroids and begin migrating 
medially and caudally until they reach their final destination anterior to the heart at 
approximately E14.5 (reviewed in (19)). Separation of the common primordia and 
migration of the thymic lobes is mediated, at least in part, by NCCs (53). 
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Establishment of an organized functional thymic vasculature is dependent upon 
signals from TECs such as VEGF (reviewed in (54, 55)). Endothelial cells enter the 
developing thymus around E14 and become organized into a vascular network that 
will later function as both an entry and exit site for thymocytes and mature T-cells, 
respectively, (reviewed in (19)). 
 
Molecular mediators of 3rd PP development and thymus organogenesis 
The initial stages of thymus organogenesis begin with formation and positioning 
of the pharyngeal arches and pouches. Previous analysis of mouse models 
deficient in transcription factors implicated in organ patterning, have revealed a role 
for these factors in early thymus organogenesis. However, how these signals are 
integrated into a transcriptional network that functions to support pouch formation 
and initial thymic development is unclear. Loss of the genes discussed below may 
result in thymus aplasia, hypoplasia or ectopia. However, their precise roles in 
thymic organogenesis is complicated by their pleiotropic effects on other aspects of 
embryonic development.   
The transcription factor Hoxa-3 is thought to play the earliest role in specifying 
the 3rd pouch PP and initiating thymus and PT formation (56-58). Mice harboring a 
mutation in Hoxa3 are characterized by numerous pharyngeal defects, lack 
parathyroids and are athymic (57). Hoxa-3 is expressed in both 3rd PP endoderm 
and in NCC mesenchyme at E10.5, however only its endodermal expression is 
thought to be required for 3rd PP specification and formation, as mice with a NCC-
specific deletion of Hoxa-3 initially develop normally patterned 3rd PPs but 
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separation of the common primordia does not occur and there is a failure of organ 
migration, (reviewed in (58)). Hoxa-3 is expressed in the pharyngeal endoderm at 
E10.5 and persists in the TEC compartment during later stages of organogenesis 
(reviewed in (58)). TEC-specific deletion of Hoxa-3 after pouch formation and 
specification caused no apparent defects in TEC development (reviewed in (58)), 
suggesting that Hoxa-3 function in thymus may be limited to an early window in 
development.  
While the direct downstream targets of Hoxa-3 are not yet known, potential 
effectors of its function include the transcription factors Pax-1 and Pax-9, which are 
both expressed throughout the pharyngeal pouches ((59, 60) also reviewed in (19)). 
Knockout mice for Pax-1 or Pax-9 develop hypoplastic thymi that range in severity, 
with Pax-9 null mice having the most pronounced defects (reviewed in (58)).  Given 
their overlapping pattern of expression and structural similarity, it has been 
suggested that these factors play functionally redundant roles in the pharyngeal 
endoderm, although analysis of thymic development in compound mutants has yet 
to be performed. A redundancy in gene function is a likely explanation for the failure 
of either null model to precisely phenocopy Hoxa-3-/- thymic defects. Studies 
performed in the Manley lab analyzing development in Hoxa-3+/-, Pax-1-/- mice have 
shown impaired TEC differentiation, proliferation and survival resulting in significant 
thymus hypoplasia (59, 60). In addition, these mice fail to develop normal 
parathyroid glands as a consequence of their inability to sustain normal Gcm2 
expression (59). These data reveal that the phenotype found in Pax-1 null mice is 
enhanced by the loss of a single copy of Hoxa-3, suggesting that these factors 
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interact to regulate development of the 3rd PP (59). Compound homozygous Pax-
1/Pax-9 null mice have a normal expression pattern of Hoxa-3 in the endoderm and 
mesenchyme further implicating its upstream effector position in these tissues (61).  
Additional downstream mediators of Hoxa-3 signals include Eya-1 and Six1/4 
(61). Eya-1 is a transcriptional co-activator expressed in pharyngeal endoderm, 
ectoderm and mesenchyme (61).  Expression of the drosophila homolog Six-1 is 
similar to that of Eya-1 except it is not expressed in derivatives of the fourth pouch. 
(61) Both factors have been found to physically interact during development and 
play an indispensible role in thymus and parathyroid organogenesis, as null 
mutations of either Six-1 or Eya-1 result in thymus and parathyroid aplasia (61).  
Six-4 is also a member of the Six family of transcription factors and is closely 
related to Six-1. Both Six-1 and Six-4 have been found to have synergistic roles in 
regulating genes expressed in the 3rd PP (61).  
Eya-1 null mice are blocked at early stages of thymus development and fail to 
express detectable levels of either Foxn1 or Gcm2; however, Hoxa-3 expression is 
preserved and expression of Pax-1/9 from E9.5-E10.5 was not altered (62). Xu et. 
al., describe a reduction in Six-1 expression in Eya-1 homozygous null mice in 
regions where the two genes have overlapping patterns of expression suggesting a 
requirement for Eya-1 in Six-1-dependent tissues (62). Six-1-/- mice express 
reduced levels of Foxn1 and initiate Gcm2 within the 3rd PP but fail to sustain its 
expression. Hoxa-3 expression however is not altered in either single (Six-1-/-) or 
double (Six-1-/-, Six-4-/- and Six-1-/-, Eya-1-/-) mutants suggesting it lies genetically 
upstream of these factors (62). In addition normal Eya-1 expression has been 
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observed in Six-1-/- mice (61). Taken together these data suggest a model in which 
Eya-1 initiates early stages of patterning, downstream of Hox-3, and subsequently 
promotes the expression of Six-1/4 to maintain this developmental blueprint.  
The direct molecular mechanisms by which Eya-1 and Six-1/4 act to regulate 
Foxn1 and Gcm2 expression and patterning in the 3rd PP are unclear. However 
several recent developmental clues have emerged. Tbx1 and its downstream target 
Fgf8 appear to be initially expressed independently of Six-1/4 (63). Although Tbx1 
and Fgf8 expression are reduced in the 3rd PPs of Six-1/4 homozygous null mice, 
this may be due to secondary defects in pouch formation as investigators have 
observed an overall smaller 3rd PP(61).  Studies analyzing Eya-1 null mice showed 
reduced expression of Tbx1 and Fgf8 as well as a complete loss of the Wnt 
glycoprotein Wnt-5b, a potential upstream regulator of Foxn1 in the 3rd PP (63). This 
suggests some of the morphogenesis defects observed are at least in part mediated 
through regulation of these factors. A clear understanding of this transcription factor 
network is complicated by the fact that Eya-1 null mice fail to form a shared thymus-
parathyroid primordia preventing a detailed analysis of gene regulation during later 
times in development (62, 63). Absence of shared thymus-parathyroid primordia 
limits the conclusions that can be drawn considering the profound consequences 
that occur due to loss of this structure. Clearly, the initial molecular events involved 
in specifying the 3rd PP are necessary for formation of the shared organ primordia. 
However it is difficult to pinpoint the requirement for these genes in an exact cell 
type(s) for the purposes of correlating gene deficiencies with specific defects as 
almost all of these factors are found in multiple cell types each of which participate 
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in inductive interactions responsible for influencing cell fate decisions and 
organogenesis.  
Another molecular player implicated in patterning of the pharyngeal endoderm 
and thymic development is the morphogen Sonic hedgehog, Shh. Shh is a secreted 
glycoprotein that can migrate distances from 80-300µm, exerting its effects in a 
concentration-dependent manner. The Shh pathway is activated when Shh ligand 
binds to the twelve-pass transmembrane protein Patched (Ptc). When Ptc is not 
bound to Shh ligand it represses the adjacent transmembrane receptor 
Smoothened (Smo), the Shh signal transducer. Binding of the Shh ligand to Ptc 
releases this repression and allows the Gli family of transcription factors Gli1-3 to 
translocate into the nucleus where they can exert their activity on downstream  
Shh-responsive target genes.  
Shh and its receptor Ptc are expressed in a restricted manner within the 
pharyngeal endoderm and arch mesenchyme (51). Ptc is up-regulated during 
activation of the Shh pathway and is therefore used as readout of Shh activity.  At 
E10.5-E11.5 Shh expression is found throughout the pharyngeal endoderm in 1st 
and 2nd PPs but is absent from the 3rd and 4th PPs (51). At the same time Ptc is 
expressed not only throughout the first and second arches and surrounding 
mesenchyme, similar to its ligand Shh, but also in the distal tips of the 3rd PP 
endoderm where Shh expression is absent (51). This suggests that while the dorsal 
anterior region of the 3rd PP does not produce Shh ligand it remains competent to 
respond to gradients of Shh that are produced by other cells types.  
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Interestingly, E11.5 Shh null mice lack expression of Tbx1 and, similar to 
Splotch mice, have an expansion of the thymus-fated Foxn1-domain in the 3rd PP 
(51). This expansion however was more pronounced extending throughout the 
organ primordia and into the pharyngeal region (51). Gcm2-expression was 
completely lacking from E10.5 onwards eventually resulting in an aparathyroid 
phenotype (51). Studies by previous investigators have shown Shh regulates 
expression of Tbx1 in the pharyngeal endoderm through transcriptional activation of 
the transcription factors Foxa2 and Foxc1/2 (64, 65). 
 
The Role of Tbx1 in 3rd PP formation and fate determination  
The transcription factor Tbx1 is required for development of the pharyngeal 
apparatus and is most commonly investigated in the context of the several 
syndromes associated with deletions in human chromosome 22q11.2, (reviewed in 
(66)). DiGeorge’s syndome (DGS) and velocardiofacial syndrome (VCFS) result 
from such deletions and arise in 1:4000 live births (reviewed in (66)). The majority of 
affected individuals have a hemizygous deletion that ranges in size from 1.5-3kb 
and affects 23-35 genes, including Tbx1 (reviewed in (66)). Individuals affected by 
either syndrome display common defects such as thymus aplasia or hypoplasia, 
craniofacial abnormalities, hypoparathyroidism and cardiac abnormalities (reviewed 
in (67)). These disease components vary in presentation and severity and a specific 
phenotype does not coincide with known deletions, as even individuals with the 
same deletion can vary drastically in the defects they present (reviewed in (66)). 
This variation is thought to be mediated, at least in part, by genetic modifiers, which 
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either restrict or enhance the phenotype (reviewed in (66)). A clear understanding 
and identification of these factors has yet to be obtained; however it is postulated 
that Fgf8 and the retinoic-acid-signaling pathway may be involved (68-70). 
Tbx1 belongs to the T-box family of transcription factors, which includes over 
twenty members each containing a common DNA binding sequence referred to as a 
T-box, (reviewed in (71)) . Expression of Tbx1 in the developing embryo is found in 
the pharyngeal endoderm, and arch mesenchyme but not in NCCs, (reviewed in 
(58)). Initially at E9.5 Tbx1 is expressed throughout the 3rd PP but by E10.5 it 
becomes restricted to the dorsal parathyroid-fated domain and is turned off in the 
ventral thymic-fated domain (reviewed in (19)). Mice harboring homozygous mutant 
alleles of Tbx1 rendering it functionally null are characterized by athymia, lack 
parathyroids and exhibit severe cardiac abnormalities resulting in late embryonic 
lethality (72). Heterozygous mice are viable but display milder cardiac abnormalities 
associated with DiGeorge/VCF, owing to a reduction in gene dosage (72, 73).  
These defects widely overlap those observed in patients with the human syndromes 
leading to the widely held belief that Tbx1 plays a direct role in promoting thymus 
organogenesis.     
Early work by Jerome et. al., identifying Tbx1 as a major candidate gene 
responsible for many of the DiGeorge/VCF phenotypes, showed that Tbx1 is 
required for formation of pharyngeal pouches 2-4 and therefore also for formation of 
the organs and tissues they later give rise to (72). Temporal and tissue-specific 
deletion of Tbx1 in the pharyngeal endoderm has been achieved by generating 
Foxg1Cre/+, Tbx1flox/null mice (74). The transcription factor Foxg1 is expressed 
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throughout the pharyngeal endoderm early in mouse development (75). Foxg1Cre/+, 
Tbx1flox/null conditional mice show a lack of Tbx1 expression by E9.5 in the 
pharyngeal pouches and endoderm (74). The resulting phenotype observed was 
indistinguishable from Tbx1-/- mice suggesting Tbx1 is required by the pharyngeal 
endoderm for pouch formation in a cell-autonomous fashion (74).  
Interestingly, conditional null mice were also found to have muscular and 
skeletal defects attributable to defects in proper NCC-migration and consequently 
development of these plastic cells into their prospective structures (74). This 
implicates a non-cell autonomous role for Tbx1 in NCCs. It is postulated that NCC-
specific defects observed in the pharyngeal endoderm and its derivatives occur 
secondary to abnormalities that arise as a failure of pouch formation. Although 
NCCs to do not express Tbx1, inductive interactions from the pharyngeal endoderm 
are required for their migration and distribution throughout the embryo (72, 76, 77). 
Studies using a genetic approach to specifically delete Tbx1 in mesodermal 
mesenchyme (non-NCC derived) have also found a similar requirement for Tbx1 in 
mediating reciprocal interactions for the mutual development of both cell types and 
remodeling the pharyngeal endoderm (77). Thus, Tbx1 is genetically pleiotropic, 
and functions dynamically in different cell types that cooperate in proper formation 
and outgrowth of the pharyngeal apparatus.   
In addition, Tbx1 function also varies temporally and plays different roles 
depending on developmental stage and context. This has been demonstrated by in 
vivo experiments in which timed deletions of Tbx1 were performed at various 
gestational ages (78). In short, Tbx1 deletion was achieved by generation of the 
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drug-inducible conditional mouse model, Tbx1flox/+, TgCAGG-CreERTM, in which 
site-specific activation of the Cre recombinase occurs upon injection of tamoxifen 
resulting in excision of a Tbx1-coding exon (78). Deletion of Tbx1 at E7.5 resulted in 
a phenotype that was identical to that observed in homozygous Tbx1 null mice, 
(abnormalities of the aortic arch, cardiac outflow tract, development and aplasia of 
the thymus and aberrant formation of the palate) (78). Injection of mice with 
tamoxifen one day later, E8.5, resulted in a milder phenotype (78). Pharyngeal arch 
arteries of the 4th PP, which later give rise to regions of the aorta, subclavian and 
carotid arteries in the adult heart, were only mildly hypoplastic or normal (78).  
These outflow tract abnormalities occurred to a lesser degree upon deletion at E9.0-
E9.5 implying a time-sensitive developmental window through which Tbx1 acts to 
pattern the 4th PP arteries (78).  
Interestingly, normal thymus formation required Tbx1 expression prior to E9.5, 
preceding development of the primordia (78). This suggests a model in which 
thymic development requires the establishment of segmented pharyngeal arches 
and pouches, which in turn require expression of Tbx1. Loss of Tbx1 at E10.5, a 
time during which outgrowth of the 3rd PP normally occurs, was reported to impair 
formation of the 3rd PP and therefore, result in a hypoplastic thymus (78). In 
addition, Tbx1 positive cells were found to contribute to a small percentage of cells 
within the late fetal thymus, however the authors did not elaborate on the identity or 
precise contribution of these cells (78).  
This suggests a model for thymus organogenesis in which initial patterning of  
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the pharyngeal endoderm and subsequent formation of the 3rd PP is orchestrated 
through a Hoxa3-Pax-1/9-Eya-1-Six-1/4 transcription factor network. Subsequent 
patterning of the 3rd PP into organ-specific domains is required and mediated by 
Shh-dependent activation of Tbx1, a candidate master regulator of patterning 
events in the 3rd PP. Shh regulates Tbx1 expression in the pharyngeal endoderm 
and is required for expression of Gcm2 and thus establishment of parathyroid 
identity (51, 64). Gcm2 null mice lack parathyroids but have a normal expression 
pattern of Tbx1 at E10.5 in the 3rd PP, suggesting an upstream role for Tbx1 in 
maintaining Gcm2 expression. Taken together, the following signaling cascade 
emerges for establishment of normal patterning events in the 3rd PP. Shh regulates 
Gcm2 expression through Foxa2/Foxc2-dependent activation of Tbx1 in the 
pharyngeal endoderm. While we propose that Tbx1 is required for the establishment 
of parathyroid identity in the 3rd PP, we speculate that it is not permissive for normal 
thymic maturation. 
It is possible that Tbx1 expression in the 3rd PP could play a role in 
development that promotes thymic organogenesis. However, data obtained from the 
Manley and Richie labs as well as data presented in later chapters of this 
dissertation, contradict this documented prediction and support the notion that Tbx1, 
while initially required for the development of the pharyngeal pouches, promotes the 
establishment of parathyroid identity in the 3rd PP and must be down-regulated in 
the ventral-posterior thymus fated domain at E10.5 for normal thymus 
organogenesis to occur.  In order to test the hypothesis that Tbx1 expression must 
be down-regulated in the ventral-thymus fated domain for normal thymus 
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development to occur, we generated Tbx1 inducible mice that activated and 
sustained Tbx1 expression early in embryogenesis in all Foxn1-expressing cells, 
therefore in all TECs, and subsequently investigated thymic development.  
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Materials and Methods 
 
Generation of mice and of embryonic tissues 
Conditional R26CAGGTbx1-GFP mice were generated using a vector kindly 
provided by A. McMahon that was modified and targeted to the R26 locus.  Tbx1 
cDNA as well as an IRES-GFP were inserted downstream of a stop-floxed polA site 
and under the control of a strong CAGG promoter. In the presence of Cre, 
recombination occurs resulting in excision of the stop cassette and conditional 
expression of our target gene. The modified construct was electroporated into 129 
mouse embryonic stem cells and positive cells were selected for based on their 
ability to grow in neomycin containing media. Several clones were given to the UT 
Austin Mouse Genetic Engineering Facility for injection into C57Bl/6 blastocysts. 
Chimeric mice were generated and mated back to C57Bl/6 mice. The resulting 
litters were selected for based on coat color. Black mice were characterized by 
southern blot analysis and PCR analysis. Two founder lines positive for germ line 
transmission were bred and used for initial characterization. Both yielded identical 
thymic phenotypes when crossed with Foxn1Cre, gifted from N. Manley (49). For the 
duration of the study only mice derived from a single founder were used to generate 
progeny harboring the conditional allele.  The colony was breed back to C57Bl/6 for 
maintainence of the line.  R26iTbx1/+ mice were set up for timed matings with 
Foxn1Cre/Cre mice. The morning of a vaginal plug was considered as embryonic day 
0.5 (E0.5) 
 
	  	   33	  
Sothern Blot Analysis 
This protocol was adapted from an established protocol in the lab of Dr. Mark 
Bedford. Mouse tails were inoculated and digested in 0.5ml of Proteinase K 
(10mg/ml) (Ambion) and Tail Lysis Buffer mixture (17µM Tris-HCl (Fischer) pH 7.5, 
17µM EDTA (Fischer) 170µM NaCl, 0.85% SDS (Fischer) at 50°C until fully 
digested. After this, add 0.25 mLs of saturated NaCL (5-6M). Shake 200 times and 
chill for 10 minutes on ice. Spin in microcentrifue at 6K for 5 minutes. Transfer 
0.5mL of the upper layer to a new tube and add 1mL of 100% EtOH and mix. Spool 
DNA with a capillary tube. Rinse with 70% EtOH and air dry for a few minutes. 
Resuspend the DNA in 100uL of water. Cut 15µL of DNA (in 30µL volume) with 
EcoRV restriction enzyme (NEB labs, use 50 units of enzyme/30µL reaction) and 
digest for 3-5 hours at the appropriate temperature. Run the digest on a 0.8% 
agarose gel at constant voltage of 35V overnight or 50V for 8 hours. Take a picture 
of the gel with a ruler next to it, lining the wells to the ruler. Denature the DNA by 
soaking the gel in denaturing solution (1.5M NaCl/0.5M NaOH) for 30 minutes at 
room temperature with agitation. Neutralize the gel in neutralizing solution (0.5M 
Tris-HCl pH 7.5/1.5 M NaCl) for 30 minutes at room temperature while shaking. 
Next perform the gel transfer as follow. Wrap a piece of Whatmann 3MM paper 
around a piece of plexiglass and place the wrapped support inside a large baking 
dish. Fill the dish with 10X SSC and smooth out bubbles in the paper. Place the gel 
on the damp 3MM paper, making sure there are no air bubbles between the gel and 
the membrane. Cut the membrane to the size of the gel and float it on a solution of 
2XSSC until it wets completely. Immerse the filter in 2XSSC for 2-3 minutes. Then 
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place the wet membrane on top of the gel and carefully remove any air bubbles 
between the gel and the membrane. Place a piece of dry 3MM paper that is the 
same size as the gel and again remove air bubbles from the wet and dry papers. 
Place a stack of paper towels onto of the 3MM paper. Place a glass plate on top of 
this stack and weight in down. Allow the transfer to proceed for about 6-24 hours. 
After this transfer, cross-link the DNA to the membrane by exposing the filter to UV 
irradiation. Generate the radioactive probe as follows using instructions from the 
Stratagene probe kit (Agilent Technologies). During probe labeling add 2X SSC to 
pre-wet the membrane. Drain and add 10mLs of hybridization buffer/ “SLURP”  
plus 500µL of 20% SDS. SLURP/Hybridization Solution: 200 mLs 50% dextran 
sulfate, (Amersham), 480mLs formamide deionized (Americ. Bioan), 240mLs 
20XSSC, 20mLs 1M Tris-pH7.5, 10mls 100x Denhardt’s, 1ml 20mg/mL herring 
sperm DNA (boiled 10 minutes). Incubate at 42°C for at least 15 minutes. After 
completion of probe labeling, add 50µL of salmon sperm DNA and run the probe + 
salmon sperm DNA over a G50 Sephadex column  (Amersham). Collect the eluted 
sample and use 1 µl to count over the scintillation counter. Boil the probe and the 
salmon sperm for 5 minutes and then place it on ice for 5 minutes. Then add the 
probe to the membrane + hybridization buffer and incubate overnight at 42°C. The 
next day wash the membranes in 50mLs of 0.5SSC/0.1% SDS at 65°C for 10 
minutes each. Expose to auto-rad (BioRad) cassette.  
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In Situ Hybridization 
Dissection tools and materials were wiped with RNase OFF (Ambion) prior to 
use according to the manufacturers instructions in order to avoid contamination with 
RNases.  Slide mailers were soaked in 1M sodium hydroxide overnight, rinsed with 
dH20 and autoclaved to sterilize prior to use. Embryos taken for in situ hybridization 
were collected in 1X DEPC (diethylpyrocarbonate)-treated (Sigma) 1X-phosphate-
buffered saline (PBS) (Hyclone).  Tissue was allowed to fix overnight in 4% 
parafolmaldehyde (PFA)/1XDEPC PBS overnight and then dehydrated in a gradient 
of Ethanol/DEPC-H2O dilutions as follows: 30, 50, 70, 80, 95, 100%. Incubations 
were performed at 4°C for 10 minutes. Dehydrated tissue was then paraffin-
embedded and sectioned using 1X DEPC H20 at 10µm for analysis. Sectioned 
slides were dried overnight in a 37°C incubator overnight. The following day slides 
were placed in pretreated slide mailers and de-paraffinized in Citrisolve (Fischer 
Scientific). Two 15-minute washes were performed using this solution. After 
dewaxing, slides were rehydrated using a series of EtOH/DEPC H20 solutions as 
follows: 100, 95, 90, 70, 70 50 and 30%.  With the exception of the first 100% wash, 
all washes were performed once for 2 minutes at room temperature. The first wash 
was performed twice, 5 minutes per wash. The last wash was then preceded by two 
5-min washes in 1XPBS. Slides were re-fixed in 4% PFA/1XDEPC PBS for 20-
minutes and washed twice, 5 minutes per wash in 1X PBS. This was followed by 
two 2-minute washes in 2XSSC and then a 30 minute incubation in Tris/Glycine 
buffer which is made as follows: Tris-base 12.1g/L / Glycine 7.5g/L. Sections were 
then placed flat on top of a humidity chamber containing 250µL with 2XDEPC SSC. 
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Each slide was covered with hybridization solution containing the appropriate dig-
labeled riboprobe. Hybridization buffer was made as follows: 50% Formamide 
(Ambion), 5X SSC DEPC-treated, 50 mg/mL Heparin (Sigma), 0.1% Tween 20 
(Sigma), 100 mg/ml tRNA (Sigma), 5% dextran-sulfate (Sigma), 8mM citric acid 
(Sigma). Probes were diluted 1/55 and an appropriate volume was applied to each 
slide depending on the number of tissue sections per slide (for 2 pieces of tissue a 
volume of 55µL was applied). The total volume was adjusted for slides that 
contained more pieces of tissue by doubling or tripling if necessary. Slides were 
then covered with pieces of parafilm (Fischer) that had previously been cut to size. 
Humidity chambers were wrapped in cellophane wrap and aluminum foil and placed 
in the 65°C overnight to incubate. The following day the parafilm was removed and 
slides were transferred to new slide mailers and washed at 65°C three times in 0.5X 
SSC/2% formamide for 20 minutes per wash. During the last incubation, NTE buffer 
(292g NaCl, 100mMTris pH7.5, 50mM EDTA (all from Sigma)) was pre-warmed to 
37°C. Slides were then washed for 15 minutes in NTE at 37°C. After this time the 
NTE solution was replaced with NTE containing 10mg/mL RNase A. The slides 
were incubated at 37°C for 30 minutes and then washed in NTE alone for 15 
minutes again at the 37°C.  After this, the slides were washed again in 0.5X 
SSC/2% formamide at 65°C. Four washes were performed for 1 hour each. Slides 
were then rinsed with 2XSSC DEPC-treated at room temperature for 30 minutes. 
Next, slides were blocked for one hour at room temperature in 1% blocking solution 
(Roche) diluted in MABT. MABT can be made as follows: 11.6g/L Maleic Acid 
(Sigma), 8.8g/L NaCl, pH to 7 and then add 0.1% Tween 20.  Following this 
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blocking step, alkaline phosphatase-conjugated anti-Dig Fab fragments (Roche) 
were diluted in the 1% block/MABT at a 1:5000 concentration. Slides were placed 
on top of a humidity chamber as done before. 500µL was added to each slide and 
again a pre-cut parafilm cover slip was placed on top. Boxes were wrapped as 
previously described and left overnight to incubate at 4°C. The following day each 
parafilm strip was removed and the slides were washed with TBST at room 
temperature. TBST can be made as follows: 150mM NaCl and 10mM Tris-HCl  
pH 8.0, 0.1% Tween 20. One 5-minute wash was performed first, followed by one 
10 minute wash, and then one 20 minute wash.  This was followed by seven 1 hour 
washes performed at room temperature. After this time slides were incubated for 10 
minutes in alkaline phosphatase buffer made as follows: 100mM Tris pH 9.5, 50 mM 
MgCl2, 100mM NaCl, 0.1% Tween 20 and 0.5mg/ml levamisol (Sigma). After this 
incubation slides were placed on an incubation chamber and BM purple (Roche) 
was applied. The incubation chamber was covered in foil, placed in the dark and 
allowed to develop for 1-5 days. After the desired color reaction was obtained, 
slides were rinsed in PBST (1XPBS, .01% Tween 20) for 5 minutes 3 times and 
then counterstained with nuclear fast red. Slides were then mounted using Cytoseal 
(Thermo Scientific) for viewing.  
 
Plasmids for generation of dig-labeled mRNA riboprobes 
Both Foxn1 and Gcm2 plasmids were gifts from Dr. Nancy Manley.  
 
 
	  	   38	  
 
Generation of riboprobes 
Gcm2 plasmid was digested with the restriction enzyme NcoI (Promega) and 
Foxn1 AccIII (Promega) according the manufacturers instructions. Purification of the 
digest was performed by phenol chloroform extraction as follows. Volume was 
brought to 400µl with 1XDEPC H20 and 400µl of phenol chloroform was added. 
Mixing was performed by vortexing for 1 minute. Spin for 10 minutes at 14K rpm 
and remove top phase to a new tube. Add 400µl of phenol chloroform to this top 
layer and repeat vortex step. Spin for 8 minutes at 14K rpm. Remove the tops 
phase and add 0.1% volume of 3M NaOH (made up with DEPC H20) plus 2.5 times 
the volume of 100% EtOH. Place this sample at -80°C for 30 minutes or more. Then 
spin sample at 14K rpm for 15 minutes and remove supernatant. Wash with 70% 
EtOH/DEPC H20 for 5 minutes and then spin at 14K for 5 minutes. Air dry and then 
resuspend DNA in 15µl of DEPC H20.  In vitro transcription was performed in a  
20µl reaction with SP6 (Roche) for Gcm2 or T3 (Roche) for Foxn1 according to the 
manufacturers instructions. Precipitation of the product was performed by adding 
1.8µL of 8M LiCl (made with DEPC H20) and 58.5µL of 100% EtOH. Samples were 
then placed at -80°C for at least 2 hours. Samples were then spun at 14k rpm for 15 
minutes at 4°C. Supernatant was removed and the pellet washed in 70% 
EtOH/DEPC H2O. Spinning was again performed at 14K for 10 minutes. The 
supernatant was removed and the pellet allowed to air dry. The probe was then 
resuspended in 80µL of DEPC H20, aliquoted and stored at -80°C for later use.  
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Preparation of adult and fetal tissue for epithelial FACS analysis 
Adult thymi were dissected and prepared according to the standard protocol 
established in Gray et. al (79). Fetal thymi were harvested in RPMI (Fischer)/5% 
fetal calf serum (Hyclone). R26iTbx1/+ thymi were pooled for digest and control thymi 
were digested in pairs. Both genotypes were digested in 1.5mL eppendorff tubes 
(BioExpress) using the collagenase/DnaseI solution referenced in Gray et. al (79) 
Unlike adult thymi, fetal thymi were digested for two to three 10 minute incubations 
only in a 37°C water bath without agitation and the collagenase/dispase digestion 
steps omitted. Both adult and fetal epithelial cells preparations were counted using 
trypan blue viability stain (Fischer) and a Countess® automated cell counter 
(Invitrogen). Cells were then distributed into FACS polystyrene tubes (BD Falcon) 
for staining.  
 
Preparation of thymic tissue for thymocyte FACS analysis 
Tissue from adult mice was dissected in 1XPBS/5% fetal calf serum and then 
pressed through a 70-micron cell strainer (Falcon) placed over a 50ml conical tube 
(Fischer) for collection. Using the plunger end of a 3ml syringe (BD Biosciences) 
thymi were pressed through a strainer. Strainers were rinsed with 1XPBS and the 
cell suspension was collected in the conical tube below. Tubes were spun down at 
4°C at 1250 rpm. The supernatant was removed and the cell pellet resuspended in 
1XPBS. Cells were distributed in polystyrene FACS tubes for addition of antibodies.  
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Antibodies used for FACS 
Cells from fetal or adult thymi were stained with the following primary 
antibodies, anti-CD45-PerCPCy5.5 (eBioscience), anti-EpCAM-PeCy7 (Biolegend) 
or anti-EpCAM-APC (Biolegend), anti-CD4-efluor-605 (Invitrogen), anti-CD8-PeCy7 
(eBioscience), anti-CD80-PE (eBioscience), anti-Ly51-biotin (BD Pharmigen), anti-
MHCII-Pacific Blue (Biolegend), antiCD44-APC (eBioscience), anti-CD25-Alexa488 
(eBioscience), anti-CD3-biotin (eBioscience) or anti-CD3-PE-Cy5 (eBioscience), 
CD117-PE-Cy5 (eBioscience), CD127-PE-Cy5 (eBioscience) αβTCR-PE-Cy5 
(Biolegend) γδTCR-PE-Cy5 (eBioscience), TER119-Pe-Cy5 (eBioscience), Gr1.1-
PE-Cy5 (eBioscience), Nk1.1-PE-Cy5 (Biolegend).  Primary antibodies were 
incubated for 15 minutes and cells rinsed with FACS wash buffer, (as prepared in 
(79)). Samples were spun at 1400 rpm for 4 minutes and the supernatant removed. 
Secondary antibodies were added if necessary.  Secondary antibody used were: 
SA-qDot655 (Invitrogen). Incubation of this secondary antibody was performed in 
the dark for 15 minutes. Samples were then rinsed and spun as before. Cells were 
resuspended in 1XPBS for FACS analysis using the AriaII or Fortessa benchtop 
analyzer (BD). Analysis of data obtained from FACS was performed using the 
program FlowJo (version 9.3) by Treestar. 
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BrdU FACS  
BrdU FACS analysis was performed in fetal thymi by injecting 300µl,	  
intraperitonealy (IP), of a 10mg/mL (BD Pharmigen) stock solution into pregnant 
mice 7 hours prior to sacrifice. Fetal thymi were prepared using the above protocol 
and stained for surface antigens. After surfacing staining, samples were prepared 
according to the manufacturers instructions found in the Brdu-APC labeling kit (BD 
Pharmigen). 
 
FACS staining of thymi 
BrdU (BD Pharmigen) was injected, same concentration as above, into 
pregnant dams or individual mice (IP) 90 minutes prior to sacrifice. Thymic were 
frozen and sectioned at 10µM. Slides were stained according the to manufactures 
instructions (BD Pharmigen).   	  
TUNEL Staining 
Staining was performed on cryopreserved sections. Slides were warmed to 
room temperature and staining was performed according to the manufacturer’s 
instructions in the kit (Roche) for cytopreserved tissue sections. 
 
Immunohistochemistry 
Hematoxylin and eosin staining was performed on paraffin slides sectioned at 
5-10µM in thickness. Staining was performed as follows. Dewax sections in xylene 
for 2 incubations, 10 minutes each. Rehydrate tissue through decreasing ethanol 
	  	   42	  
dilutions as follows: 100%, 96%, 90%, 70% for 5 minutes each. Then rinse 5 
minutes in tap water. Apply Hematoxylin (Fischer) for 3-10 minutes. Rinse under 
running tap water until water runs clear. Apply Eosin (Sigma), dilute a 1% stock to 
1:50 for use and add three drops glacial acetic acid, for 3-10 minutes. Rinse as 
before. Dehydrate through a rapid ethanol series as follows: 70%, 90%, 96% and 
100%. Rinse in xylene (Fischer) twice for five minutes each. Coverslip with cytoseal. 
(ThermoScientific). 
Immunohistochemistry was performed in frozen sections as follows. Warm 
slides to room temperature. Acetone fixation was performed for 20 minutes at 4°C, 
unless sections were fixed prior to sectioning. Rinse for three 5-minute incubations 
in TNT (Perkin Elmer) made according to the manufacturers instructions). Slides 
were blocked for 15 minutes using block provided in TSA kit (Perkin Elmer), 
prepared according to the manufacturers instructions. Primary antibodies 
((1µg/µL)/tissue section in TNB) were incubated for 1-hour at 4°C and rinsed for 
three incubations of 5-minutes each. Secondary antibodies were diluted at 
((1µg/µL)/tissue section in TNB) and applied for 30 minutes. Sections were rinsed 
three times for 5 minutes per wash and Dapi 1:1500 of a 1 mg/mL stock (Vector 
labs) was applied for 5 minutes. Slides were rinsed 3 times at 5 minutes per 
incubation and mounted with Vectashield (Vectashield) mounting medium. The 
following primary antibodies were used for immunohistochemistry without 
amplification by a TSA-system: K5 (Covance), K14 (Covance), UEA-Biotin (Vector), 
Pancytokeratin (Sigma), K8 (Troma-1), gift from Manley lab. The following primary 
antibodies were used with a TSA amplification kit (Perkin Elmer). MHCII 
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(Biolegend), Cleaved Caspase-3 (Cell Signaling), Pparγ (Cell Signaling), PdgfRα 
(eBioscience), Plet-1(Millipore). Staining of cleaved-caspase-3, Pparγ and GFP 
required 4% PFA fixation of tissue prior to sectioning. Secondary antibodies applied 
were obtained from Jackson and include: SA-fitc, donkey-anti-rat-Texas-red, 
donkey-anti-rat-fitc, SA-Texas red, donkey-anti-rabbit-Texas-red, donkey-anti-
rabbit-fitc, and donkey-anti-mouse-Texas-red.  
 
Three-dimensional analysis of E11.5 pouches 
Serial sections of control and R26iTbx1/+ 3rd pouches were traced and aligned 
using the program Surf Driver. Three-dimensional rendering and volume analysis 
was also performed using this software.  
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Results 
Chapter 1. Development of R26iTbx1 mice and studies in embryogenesis 
 
Generation of the R26iTbx1 mouse model  
  
We generated a conditional knock-in strain that expresses an inducible Tbx1 
allele after Cre-mediated recombination. A targeting vector for the R26 locus was 
obtained from Dr. Andy McMahon and modified to permit temporal and spatial 
specific expression of Tbx1 (Figure 1A). Tbx1 cDNA was cloned downstream of a 
loxP-flanked poly-A stop cassette and under the control of a strong CAGG 
promoter. An IRES-GFP tag was inserted downstream of Tbx1 to confirm 
expression. 
Mouse embryonic stem (ES) cells derived from a C57/Bl6 line were transformed 
with the modified vector and grown in the presence of neomycin containing media at 
the University of Texas at Austin Mouse Genetic Engineering Facility. Antibiotic 
resistant clones were selected for injection into Bl6.SF129 blastocysts. ES cells 
were analyzed post-blastocyst injection by Southern blots to assay for the presence 
of the conditional Tbx1 allele (Figure 1B). Three clones were found to contain the 
modified vector and used for injection into blastocysts, which were then implanted 
into pseudo-pregnant dams for generation of chimeras. The resulting litters were 
analyzed and selected based on coat-color composition. We analyzed F1 founder 
lines to confirm germ-line transmission. Two founders contained the R26iTbx1 allele 
as verified by a 5kb band obtained after enzyme EcoRV digestion and Southern blot 
analysis (Figure 1C).  These mice were bred to C57Bl/6 mice for establishment of  
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Figure 1. Generation of R26iTbx1 mouse strain. (A) The modified R26 targeting 
construct contains Tbx1 cDNA under control of a strong CAGG promoter and a 
floxed-stop cassette. An IRES-GFP tag is located downstream of Tbx1. (B) 
Southern blot analysis of post-blastocyst injected ES cells containing 4.3 and 3.6 kb 
bands corresponding to R26+ and R26iTbx1 alleles, respectively. (C) Southern blot 
analysis of F1 mice confirms the presence of a 5kb wild-type (WT) band and /or a 
14kb R26iTbx1 band. (D) PCR analysis of genomic tail DNA from F1 progeny results 
in a 298bp WT band alone or in addition to a 456bp R26iTbx1 corresponding to WT 
or heterozygous progeny, respectively. 
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two separate lines, which later were confirmed to result in comparable thymic 
phenotypes when crossed with Foxn-1Cre/Cre mice (unpublished observation). After 
this initial observation, one line (Line 1) was chosen for the duration of this study 
and all experiments were performed using progeny derived from this founder. Mice 
were genotyped by PCR analysis of tail DNA. DNA from wild-type (WT) mice 
yielded a single 298 base pair (bp) band while heterozygous mice for the R26iTbx1 
allele yielded one WT 298bp band and also a 456bp indicating the presence of our 
conditional allele (Figure 1D).  
 
Expression of Tbx1 in R26iTbx1/+, Foxn1Cre/+ mice  
Foxn1 is expressed in the thymic-fated ventral domain of the 3rd PP by E11.25 
and, thus by all endodermal progenitors which give rise to the thymic epithelium 
(reviewed in (19)). Foxn1Cre/+ mice generated in the lab of Dr. Nancy Manley have 
been used to achieve spatial and temporal activation of loxP-flanked target genes 
(49). When crossed to R26LacZ/+ reporter lines staining of beta-galactosidase at 
E12.5 was found throughout the thymic epithelium. In order to activate Tbx1 in the 
ventral-thymus fated domain and sustain expression in all TECs we crossed 
R26iTbx1/+ mice to Foxn1Cre/Cre mice.  Temporal and tissue specific expression was 
analyzed by anti-GFP staining performed at E12.5, E14.5, E17.5 and 3 wks of age 
(Figure 2). GFP expression was observed as early as E12.5 in embryogenesis. 
Furthermore, GFP expression was restricted to fetal thymic lobes and later 
persisted in the adult thymus but was absent in age matched littermate controls. For 
the remainder of this dissertation R26iTbx1/+, Foxn1Cre/+ mice will be referred  
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Figure 2. Foxn1Cre induces R26iTbx1 expression in thymus epithelial cells.  (A) GFP 
expression in R26+/+,(a-c) and R26/iTbx1/+ (d-f) thymi at indicated ages. (B) FACS 
analysis of cells from E17.5 pooled thymic lobes. In the upper panel anti-EpCAM 
APC conjugate detects TECs and anti-CD45-PerCP Cy5.5 detects hematopoietic 
cells. Arrows show the gating strategy. The percentage of cells within each 
electronic gate is shown on the plot. 
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to in the text as R26iTbx1/+ while R26+/+, Foxn1Cre/+ mice will be denoted as controls 
or R26+/+.  
To further examine the specificity of R26iTbx1/+ expression pooled thymi from 
R26iTbx1/+ or R26+/+ E17.5 embryos were analyzed by flow cytometry. Thymic lobes 
were digested with collagenase to produce single cell suspensions and stained for 
the epithelial-specific marker EpCAM, as well as the hematopoietic-specific marker 
CD45. Dead cells were gated out based on propidium iodide (PI) exclusion. GFP 
was expressed in CD45- EpCAM+ TECs from R26iTbx1/+ but not control thymi. CD45+ 
hematopoietic cells and CD45- EpCAM- stromal cells were GFP negative (data not 
shown). The FACS data is consistent with the pattern of GFP staining detected by 
immunohistochemistry (Figure 2 A) and was further validated by qRT-PCR analysis 
(see Figure 10). Sorted cells from E14.5 and E17.5 thymi show Tbx1 expression in 
R26iTbx1/+ TECs but not in TECs from control thymi (Figure 10, later section). 
Furthermore, Tbx1 expression was not present in CD45+, EpCAM- cells or CD45-, 
EpCAM- cells from either genotype (data not shown). 
  
Patterning in the R26iTbx1/+ 3rd PP is conserved at E11.5  
In situ hybridization (ISH) for Foxn1 and Gcm2 was performed to analyze 
patterning in the 3rd PP at E11.5. Consistent with patterning found in control 
littermates, the 3rd PP in R26iTbx1/+ embryos showed normal ventral-anterior 
expression of Foxn1 as well as normal dorsal-posterior expression Gcm2 (Figure 3).  
Distinct non-overlapping boundaries between the thymus- and PT-fated domains 
were present in both genotypes with no obvious expansion or reduction in either  
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Figure 3. In situ hybridization of Foxn1 and Gcm2 expression in the 3rd PP. Sagittal 
sections of E11.5 R26iTbx1/+ and R26+/+ embryos were analyzed for Foxn1 (A,B) and 
Gcm2 (C,D) expression. All images were captured at 40x. Spatial orientation is 
depicted by the arrows below. n = 2  
Foxn1 Foxn1
Gcm2 Gcm2
A B
C D
R26+/+, Foxn1Cre/+ R26iTbx1/+, Foxn1Cre/+
A
P
D
V
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domain (Figure 3).  To determine whether any defects in pouch formation were 
present, overall pouch volume was measured by tracing serial sections using Surf 
Driver 3-D reconstruction software. Generation of 3-dimensional models revealed 
no significant difference in pouch volume between R26iTbx1/+ and control embryos  
(data not shown). These data suggest that establishment and patterning of the 3rd 
PP is intact in R26iTbx1/+ embryos and that the initial stages of thymus and 
parathyroid organogenesis are not impaired.  
 
Fetal thymic lobes are hypoplastic with abnormal morphology 
Timed matings between R26iTbx1/+ and Foxn1Cre/Cre lines were performed and 
the resulting litters sacrificed at various developmental stages for histological 
analysis. Expected genotypes were present at normal Mendelian ratios indicating 
there was no embryonic lethality from inducing ectopic Tbx1 expression. 
Hematoxylin and eosin (H&E) stained anterior sections were obtained from control 
and R26iTbx1/+ embryos at an anatomical location where fetal lobes are normally 
found at this developmental stage. We observed a hypoplastic thymic phenotype as 
early as E12.5 in R26iTbx1/+ embryos compared to control littermates (Figure 4 A-B). 
In addition, a prominent, expanded mesenchymal capsule was found to encase the 
R26iTbx1/+ lobes. We subsequently confirmed that these mesenchymal cells are of 
NC origin. (Figure 4 B’ and D’, Figure 22). During normal thymus organogenesis, 
the thymus rudiments are surrounded by a NC-derived mesenchymal capsule as 
seen in A’ (Figure 4). The NC-derived capsule thins during the later stages of 
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Figure 4. Embryonic R26iTbx1/+ have a progressive hypoplastic thymic phenotype. 
(A-E) Transverse sections of paraffin embedded embryos stained with Hematoxylin 
and Eosin (H&E). (A-B) Control and R26iTbx1/+ sections, respectively, at 100x lobes 
at E12.5. (A’-B’) 200x images of the corresponding lobes, note the mesenchymal 
capsule is denoted with arrows. (C-D) Transverse sections of control (C) and 
R26iTbx1/+ (D) E14.5 thymic lobes taken at 100x. (C’-D’) 200x images of the above 
lobes. (E-F) E17.5 sections of control (E) and R26iTbx1/+ (F) thymic lobes at 4x. In all 
images dorsal is up and ventral is down.  (n = greater than 3 individuals per 
genotype analyzed) 
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organogenesis as NCCs invade the thymic lobes and become pericytes that support 
the thymic vasculature. In contrast, the expanded perithymic mesenchymal capsule 
remains prominent in R26iTbx1/+ thymi even at E17.5 (Figure 22). 
The hypoplastic phenotype observed at E12.5 appeared progressive, as 
severity of this thymic defect increased during ontogeny (Figure 4). A disruption of 
normal thymic morphology was increasingly aberrant with developmental stage as 
thymic lobes became more lobular in appearance and failed to retain normal thymic 
morphology (Figure 4 D’, F).  
 
R26iTbx1/+ fetal TECs are impaired in differentiation 
H&E staining primarily shows the localization of developing thymocytes within 
the thymic lobes and does not readily detect epithelial cells in the 
microenvironment. To visualize TECs, we stained for markers of TEC differentiation, 
such as K5, K8, K14 and UEA1. At E14.5, control thymi consisted predominantly of 
K8+ cortical TECs (cTECs) (Figure 5 A). Small pre-medullary islets that costained 
with K5 and K8 were dispersed throughout the thymic lobes (Figure 5 A). This is 
consistent with work previously published by our lab describing development of the 
epithelium (21). In contrast, R26iTbx1/+ thymic lobes were highly lobulated with some 
thymi containing small adjacent epithelial regions that appeared to have detached 
from the main lobe (Figure 5 B).  K8 positive cortical epithelial regions were present 
comprising the majority of the epithelium.  K5+K8+ medullary islets formed 
aberrantly with clusters forming near the outer sub-capsular region (Figure 5 A, B). 
This epithelial phenotype appeared more severe at E17.5, suggesting it may be  
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Figure 5. TEC organization and architecture are impaired in fetal thymi. E14.5 
control (A) and R26iTbx1/+ (B-C) thymic lobes stained with K5 and K8. E17.5 control 
(D,F,H) and R26iTbx1/+ (E,G,I) thymi stained as indicated.  Magnification x100. (A-G) 
; x200 (H,I). n=2 for each genotype. 
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progressive with age. Control thymi retained normal thymic architecture with defined 
cortical and medullary subsets, expressing K5+ or K5+K8+ respectively (Figure 5 D). 
In addition the expression patterns of K14 and UEA1, (Figure 5 F and H) revealed 
two non-overlapping medullary populations as expected, one medullary TEC 
population that binds K14 and K5 but not UEA1 and another that binds K8 and 
UEA1 but not K5 or K14. In the R26iTbx1/+ thymic lobes, expression of both 
medullary markers was aberrant (Figure 5 B, C, E, G, I). An increase in K14 positive 
TECs appeared dispersed throughout the fetal lobes and did not appear to mark 
medullary populations as defined by K5 expression (Figure 5 G, I). UEA1+ cells 
appeared reduced compared to control thymi (Figure 5 G, I). Taken together, these 
data suggest TEC differentiation is aberrant in R26iTbx1/+ fetal thymi and thymic 
morphology is impaired.  
In order to further analyze TEC subsets, FACS analysis was performed on 
pooled cell suspensions from E17.5 thymi (Figure 6 A-D). The percentage of 
EpCAM+ TECs was increased in R26iTbx1/+ thymic lobes relative to control 
littermates. However, total cellularity at E17.5 was decreased by approximately 2-
fold and therefore the increased percentage of TECs reflects a decrease in 
thymocyte numbers (mean control cellularity 1.4 x106 +/- .03 (n=3) versus mean 
R26iTbx1/+ cellularity .613 x106 +/- .04 (n=5), p= .035, using standard t-test). 
Nearly all TECs obtained from control littermates expressed MHC class II 
(MHCII) (97%), suggesting they are functionally competent to present antigen to 
developing T-cells for both positive and negative selection (Figure 6 C). In striking 
contrast, TECs in R26iTbx1/+ thymi were dramatically reduced in MHCII expression,  
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Figure 6. TEC differentiation and maturation is impaired in E17.5 R26iTbx1/+ thymi. 
(A-H) FACS analysis of E17.5 pooled TECs from control and R26iTbx1/+ thymi. 
EpCAM+ MHCII- TECs (A, B) were analyzed for expression of MHC II (C, D) Ly51 
(E, F), and CD80 (G, H). Percentages of each subset are on given on the FACS 
plot. Data is consistent with three separate sets of pooled experiments. 
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with only 31% comprising the total positive TEC population (Figure 6 D). These data 
are representative of three sets of pooled experiments. Expression of the cTEC 
specific marker Ly51 showed no obvious differences in expression between control 
and R26iTbx1/+ thymi (Figure 6 E-F). CD80 is expressed on mature mTECs that 
express TRAs in the adult thymus. At E17.5 control TECs contain a small 
population of CD80 positive cells. In contrast, R26iTbx1/+ TECs almost completely 
lacked any CD80 expression, suggesting a significant maturational defect (Figure 6 
G-H). This data demonstrates that ectopic activation of Tbx1 in Foxn1- expressing 
cells results in a block in TEC differentiation and a reduction in thymus cellularity. 
 
R26iTbx1/+ are characterized by an accumulation of Plet-1 progenitor TECs 
This block is further evidenced by the expression of Plet-1, a surface antigen 
expressed by a rare population of progenitor TECs. Plet-1 is initially expressed by a 
large percentage of TECs in early thymus organogenesis but its frequency 
decreases with developmental progression ((80) and unpublished result). Plet-1 
positive TECs have also shown to be able to give rise to all epithelial cells within the 
thymus and also to support developing thymocytes when transplanted into a 
Fonx1nu/nu host (18). Examination of E14.5 thymic lobes revealed a comparable 
pattern of expression between R26iTbx1/+ and control thymi (Figure 7 A-B). In 
contrast, at E17.5 the percentage of Plet-1 positive cells within R26iTbx1/+ thymi 
appeared dramatically increased (Figure 7 C-D’’). R26+/+ thymi contained only a few 
Plet-1 positive progenitors, mostly localized to the inner medullary regions, 
consistent with a previous report documenting normal patterns of expression at this 
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Figure 7. R26iTbx1/+ thymi have an increased frequency of Plet-1+ cells at E17.5. (A-
B) E14.5 Control and R26iTbx1/+ sections stained for Dapi/Plet1 (200x) (n=3). (C-D’’) 
E17.5 Control and R26iTbx1/+ sections stained for Dapi and Plet-1 at  (C-D) 40x, (C’-
D’) 10x and (C’’-D’’) (200x) (n=3 for E14.5 and 2 for E17.5). 
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stage (unpublished data from the lab of Dr. Claire Blackburn) (Figure 7 C, C’, C’’). 
R26iTbx1/+ thymi, on the other hand, showed an accumulation of Plet-1 positive cells 
throughout the fetal lobes (Figure 7 D, D’, D’’). This immature TEC phenotype was 
reminiscent of that found in athymic Foxn1nu/nu mice which are blocked at the 
earliest stages of TEC maturation and express Plet-1 in all thymic epithelial cells 
(18). This suggests an inability of R26iTbx1/+ TECs to initiate and/ or complete a 
normal program of differentiation. 
 
R26iTbx1/+ E17.5 TECs proliferate at a frequency comparable to controls 
Given the reduced cellularity and block in TEC differentiation in R26iTbx1/+ thymi, 
we asked if these defects may result in or be attributable to aberrant proliferation. 
Immunohistochemistry and FACS analysis were utilized to address this question 
(Figure 8). Bromodeoxyuridine (BrdU) is a synthetic thymidine analog that is 
incorporated into the DNA of replicating cells, and therefore detects cells in S-
phase. BrdU was injected into pregnant dams 90 minutes prior to sacrifice at E12.5 
and E17.5. Thymic lobes were sectioned and stained for BrdU incorporation. No 
obvious defects in proliferation were noted in either E12.5 or E17.5 thymi stained 
(Figure 8 A-D).  
FACS analysis was performed to quantify the percentage of proliferating cells 
for each genotype (Figure 8 F-K). Pregnant females were pulsed with BrdU and 
sacrificed after a 7-hour chase. Control and R26iTbx1/+ thymi were identified by 
phenotype and pooled separately prior to for collagenase digestion to obtain single 
cell suspensions. We took a similar gating strategy as previously employed (refer to  
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Figure 8. Proliferation is not impaired in E17.5 R26iTbx1/+ thymi. (A-D) BrdU and 
CD45 staining of E12.5 and E17.5 frozen thymic sections. Gating strategy for FACS 
analysis of pooled control and R26iTbx1/+ thymi (E, F). TECs are EpCAM+CD45- 
TECs; hematopoietic cells are EpCAM-CD45+ (J-K); non-TEC stromal cells are 
EpCAM-CD45-. The percentage of BrdU positive cells is shown in their respective 
gates. Data is consistent with 2 separate pooled experiments. 
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Figure 6) and gated on viable cells that were negative for CD45 and positive for 
EpCAM (Figure 8 E). We found no difference in the percentage of proliferating cells 
in R26iTbx1/+ TECs as compared to the control TECs. This conclusion was confirmed 
using the proliferation specific marker Ki67, which labels dividing cells at all stages 
in the cell cycle (data not shown).  
 TEC-thymocyte interactions are essential for normal thymic development and 
are required mutually for maturation of both cell types. Differentiation blocks, for 
example a failure in MHCII expression and impaired medullary formation in the 
developing epithelium may therefore result in an impairment of thymocyte 
development and proliferation. A decrease in thymocyte proliferation could account 
for the hypoplastic thymus phenotype observed throughout ontogeny. However, 
gating on CD45+ hematopoietic cells (mainly thymocytes) showed no obvious 
difference in BrdU incorporation between R26iTbx1/+ and control littermates (Figure 8 
H-I). This was further confirmed using the same gating strategy on cells stained for 
Ki67 (data not shown). We also assessed proliferation of the group of non-epithelial 
stromal cells (e.g. fibroblasts, neural crest derived mesenchyme and endothelial 
cells) by gating on EpCAM- CD45- cells.  Analysis of this cell population, showed a 
small decrease in the percentage of BrdU positive cells in R26iTbx1/+ thymi relative to 
controls, although this difference is not appreciable (Figure 8 J-K)  
Taken together these data suggest that proliferation of TECs, thymocytes and 
non-epithelial stromal cells is not significantly affected in R26iTbx1/+ thymi compared 
to the control, thus the observed hypoplastic phenotype is not due to a reduced 
frequency of proliferating cells.  
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Fetal R26iTbx1/+ thymi have an altered pattern of gene expression but not an 
increase in cell death 
Considering the aberrant thymic morphology and significant decreases in 
overall cellularity observed in R26iTbx1/+ fetal thymi, it is possible that changes in 
apoptosis contribute to this thymic phenotype. Terminal deoxynucleotidyl 
transferase mediated dUTP n ick end labeling, or TUNEL staining, labels the free 3’ 
ends of fragmented DNA that occur as a result of programmed cell death. It is 
therefore used as an effective read-out of apoptotic activity. We utilized this system 
to label cells undergoing programmed cell death in E14.5 and E17.5 control and 
R26iTbx1/+ thymi (Figure 9). Examination of TUNEL positive cells at both ages 
revealed no obvious increase in apoptotic activity in R26iTbx1/+ thymi compared to 
control littermates (Figure 9), suggesting changes in apoptosis do not account for 
the fetal thymic phenotypes observed. Therefore changes in cell number, thymic 
architecture and morphology are mediated by a mechanism independent of cell 
death during fetal development.   
To examine transcriptional changes that result as a consequence of Tbx1 
activation in TECs we analyzed the expression of downstream candidate target 
genes such as Gcm2, Hes1 and Fgf8 as well as genes essential for normal thymic 
development such as Foxn1 and IL7 in sorted cells. cDNA was obtained from either 
E14.5 thymi as well as from thymocytes or TECs isolated by sorting pooled E17.5 
thymi. The qRT-PCR analysis was performed by TaqMan gene expression arrays. 
The endogenous house keeping genes GAPDH or α-tubulin were used to normalize 
relative expression. For each R26iTbx1/+ population analyzed the corresponding  
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Figure 9. R26iTbx1/+ fetal thymic phenotypes do not result from an increase in 
apoptosis. (A-B) Frozen sections of E14.5 Dapi and TUNEL stained thymi in control 
and R26iTbx1/+ mice (200X). (C-F) E17.5 thymi stained with Dapi and TUNEL (C-D) 
(100X) or pancytokeratin and TUNEL (E-F) 200X n= 2 pairs per age. 
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control population was used as a calibrator. As previously mentioned, Tbx1 was 
expressed in R26iTbx1/+ thymi but not in control thymi (Figure 10, top and middle 
panels). At E17.5, CD45-, EpCAM+ TECs from pooled control thymi did not express 
Tbx1; however, TECs from R26iTbx1/+ littermates showed high levels of Tbx1 
expression. Tbx1 was not expressed in EpCAM-, CD45+ hematopoietic cells or 
EpCAM-, CD45- non-TEC stromal cells from control or R26iTbx1/+ mice (data not 
shown). The pattern of Tbx1 gene expression coincides with expression of the GFP 
tag (Figure 2 B, bottom panel).  
Given that Foxn1 is required for development and homeostasis of TECs in the 
thymic microenvironment, we analyzed Foxn1 expression to determine if a 
deficiency of Foxn1 gene expression corresponds to impaired TEC development. At 
E14.5 we found no significant differences in Foxn1 gene expression in R26iTbx1/+ 
thymi relative to controls (Figure 10 A). However, at E17.5 Foxn1 levels were 
significantly reduced in R26iTbx1/+ TECs compared to controls (Figure 10 B). These 
data suggest that Tbx1 expression is antagonistic for normal expression of Foxn1 in 
fetal TECs. 
Both Gcm2 and the Notch-signaling component Hes-1 are candidate Tbx1 
target genes. Gcm2 mimics the pattern of expression of Tbx1 at E10.5 in the 3rd PP 
and is required for proper parathyroid development. During organogenesis 
expression remains restricted to the dorsal-parathyroid fated domain and is 
excluded from the ventral-thymus fated domain. While Gcm2 is required to establish 
the parathyroid-thymus fate boundary it is not expressed in the developing thymic 
epithelium and not associated with the normal TEC differentiation program. At  
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Figure 10. Expression of selected genes in R26iTbx1/+ fetal TECs. 
 qRT-PCR analysis of indicated gene expression patterns in (A) E14.5 individual 
thymi; and (B) E17.5 pooled sorted TECs, n = 3 pooled experiments (C) Preliminary 
qRT-PCR analysis of sorted E17.5 TECs. Standard t-test was performed to 
determine significance. 
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E14.5 as well as E17.5, no significant difference in Gcm2 expression was observed 
relative to controls (Figure 10).  
Hes-1 is a component of the Notch signaling pathway and plays an essential 
role in development of the pharyngeal apparatus (81). Tbx1 null mice have a 
reduction in Hes-1 and Hes-1 null mice show a range of phenotypes reminiscent of 
the human DiGeorge syndrome (81). Examination of Hes-1 in R26iTbx1/+ E14.5 thymi 
revealed a significant decrease in expression relative to controls with an average 
50% reduction in expression (Figure 10 A). This is consistent with previous reports 
that both genes act in a linear fashion to exert their dynamic developmental effects.  
Fgf8 is a downstream target gene of Tbx1 that has been implicated in thymic 
development. In the secondary heart field Tbx1 is required to respond to Fgf8 
signaling and maintain cardiac progenitor cells in an undifferentiated state. We 
analyzed relative expression of Fgf8 to determine if ectopic Tbx1 expression in 
TECs results in an altered expression pattern of this mitogen.  At E14.5 we found no 
significant difference in expression between R26iTbx1/+ thymi and controls. This 
suggests that the agonistic role Tbx1 plays in Fgf8 expression is not evidenced at 
this time during fetal gestation.  
IL-7 is a cytokine that is secreted by TECs and is required in a dose sensitive 
manner for survival and differentiation of thymocyte progenitors. In thymocytes it up-
regulates the pro-survival gene Bcl2, allowing thymocytes to escape programmed 
cell death and continue to differentiate. IL-7Rα chain, one of two chains that 
comprise the IL-7 receptor, can result in severe combined immunodeficiency 
syndrome (SCID) if deficient (reviewed in (11)). Mouse models which were treated 
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with an IL-7 neutralizing antibody or are deficient in IL-7Rα are impaired in both B- 
and T-cell development (reviewed in (11)). Taken together IL-7 secretion by TECs is 
absolutely essential for the development of a functional immune system. The 
upstream factors which regulate expression of IL-7 in TECs is not clear, but an 
thorough understanding of the mechanisms that control its expression has many 
therapeutic consequences, as it is currently being explored to increase T-cell output 
and antigen specific responses in certain immunocompromised individuals 
(reviewed in (11)).  
Analysis of IL-7 expression at E17.5 revealed a significant decrease in 
expression in R26iTbx1/+ TECs compared to TECs of control littermates (Figure 10 
B). A decrease in IL-7 expression may be attributable to an indirect or direct 
antagonism of this gene in TECs. Regardless, the decreased IL-7 expression in 
R26iTbx1/+ TECs coincides with defects found in early DN thymocyte subsets as will 
be discussed in a subsequent section (see later Figure 16). 
CCL25 is a chemokine expressed by Foxn1-dependent TECs that attracts 
thymus seeding hematopoietic cells during early stages of thymus organogenesis 
(28). Athymic nude mice have a decrease in CCL25 expression and mice deficient 
in CCR9, the corresponding receptor for CCL25 fail to recruit early progenitors to 
the thymus and are characterized by an initial decrease in thymus cellularity (28). 
Preliminary data (one experiment) using E17.5 R26iTbx1/+ TECs suggests a 
decrease in CCL25 expression relative to controls (Figure 10 C). It is tempting to 
speculate that the hypoplastic phenotype observed in R26iTbx1/+ fetal mice results, at 
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least in part, from a failure of thymus seeding progenitors to be guided by 
chemoattraction to the thymus rudiment. 
 
Postnatal R26iTbx1/+ thymi are hypoplastic with aberrant thymic architecture 
In order to determine if the thymic phenotype observed in fetal mice persisted in 
the adult we examined H&E sections at postnatal ages. Newborn (NB) control mice 
at 1-3 days of age, and mice at 1 week and 4 weeks of age had thymi with normal 
morphology in which cortical and medullary areas could clearly be delineated 
(Figure 11 A-D). In contrast, R26iTbx1/+ thymi at corresponding ages showed no clear 
demarcation of cortical and medullary boundaries (Figure 11 A’-D’). In addition, 
R26iTbx1/+ thymi had lobes that were progressively hypoplastic with age and 
contained regions that appeared acellular and highly lobulated. Thymi from these 
mice also contained areas of cells with darkly staining condensed nuclei, similar to 
cells undergoing apoptosis. Lighter staining areas dispersed throughout some lobes 
appeared stromal-like (Figure 11 A’-D’) The phenotype observed in postnatal mice 
R26iTbx1/+ was more severe than that observed in fetal R26iTbx1/+ thymi (Figure 2), 
although the degree to which thymus cellularity and organization were impaired 
varied from animal to animal and even from lobe to lobe within the same animal. 
Taken together these data suggest that R26iTbx1/+ thymi do not rebound with age 
and instead continue to degenerate progressively.  
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Figure 11. Impaired architecture and organization of postnatal R26iTbx1/+ thymi are 
progressive with age.  Hematoxylin and eosin stained thymi of control and R26iTbx1/+ 
thymi at NB (A, A,), 1wk (B, B’), and 4 wks of age (C-D’). A-C’ are frozen stained 
sections at 100x. D and D’ images are paraffin sections.
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R26iTbx1/+ TECs are impaired in differentiation and organization 
We analyzed markers of TEC differentiation and organization to assess 
postnatal TEC development and homeostasis. To evaluate the presence and 
localization of TEC subsets, the pattern of keratin expression and UEA-1 binding 
was determined by immunohistochemical analysis of frozen thymus sections from 
NB, 1 week, and 4 week mice (Figure 12). Control thymi had well-demarcated 
medullary regions containing previously described mTEC subsets. The major mTEC 
subset in the adult thymus co-expresses K5 and K14, but not K8 and does not bind 
UEA-1 (21). Another mTEC subset expresses K8 and binds UEA-1 but does not 
express K5 or K14. A minor TEC subset at the cortical-medullary junction co-
expresses K5 and K8, but does not express K14 or bind UEA-1 (Figure 12 and 
Figure 13). R26iTbx/+ thymi lacked a defined organizational architecture and instead 
contained areas that stained aberrantly. There were few well-organized medullary 
areas at any age and similar to the fetal R26iTbx1/+ fetal stages, some postnatal 
R26iTbx1/+ thymi appeared to be disintegrated. Note the small epithelial regions that 
are separated from the main lobes (Figure 13 B, E, K).) The thymus phenotype was 
consistently aberrant in the adult although the severity of disorganization varied 
from animal to animal and even between the thymus lobes within the same animal. 
While some thymic regions retained remnants of organized medullary regions, in 
most cases there was no distinct medullary organization and a paucity of mTECs 
(Figure 13 B-F, H-I, H’-I’). In particular, few UEA-1+ cells were present. Multiple 
cysts lined with K5+ epithelial cells were frequently observed (Figure 12 F-H, Figure 
13 E-F).  
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Figure 12. R26iTbx1/+ postnatal thymi at newborn and 1 week of age have a block 
in TEC differentiation.  (A, B) NB frozen sections of thymi stained with antibodies 
to detect K5 and K8 (200x), (C-D’) K14, UEA-1 and Dapi (100x);  (F-K) 1 week 
frozen thymic sections stained for K5 and K8 (40x), K14 and UEA-1 (100x). Note 
J and K were traced using Dapi staining (not shown).   	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Figure 13. 4 wk R26iTbx1/+ TECs sustain a block in differentiation. (A-C) 4 wk frozen 
thymi stained to detect K5 and K8 (40x), (D-F) K5 and MHC class II (40x). Serial 
sections of frozen 4wk thymi stained with (G-I’) K5 and K8 or K14 and UEA-1 (40x). 
(J-K) Anti-GFP and Dapi stained frozen thymi (100x). n = at least 2 per genotype  
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A positive correlation was found between the severity of the thymus phenotype and 
the extent of GFP expression. Figure 13 K shows GFP expressing cells throughout 
fragmented thymic tissue, whereas GFP+ cells are not as numerous in the relatively 
organized adjacent thymus lobe. GFP is a tag for the iTbx1 allele. Taken together 
this data show that the iTbx1 allele continues to be expressed in the adult thymus 
and as a result, defective organization, architecture and TEC maturation do not 
recover in the postnatal period.  
We performed FACS analysis in order to further investigate the block in TEC 
differentiation observed by immunohistochemistry. TECs from 3-week old R26iTbx1/+ 
and control thymi were disaggregated as previously described. We used the same 
gating strategy previously employed for fetal TEC analysis and gated on EpCAM+, 
CD45- TECs (Figure 14 A). Consistent with previous results, GFP was present in 
R26iTbx1/+ EpCAM+ CD45- TECs but not in EpCAM-, CD45+ or EpCAM-, CD45- 
populations (Figure 14 B). GFP was not observed in any population from control 
individuals. MHC class II and CD80 expression were reduced relative to controls 
(Figure 14 C, E). Similar to fetal R26iTbx1/+ TECs, Ly51 expression was comparable 
to controls. These data show that the block in TEC differentiation that is initiated 
during fetal development is sustained in adult R26iTbx1/+ thymi.  
 
Plet-1+ progenitor cells are retained in adult R26iTbx1/+ thymi 
Plet-1 is expressed at a high frequency on a large number of TEC progenitors 
during thymus organogenesis; however, this frequency declines with age  
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Figure 14. Postnatal TECs are impaired in differentiation in R26iTbx1/+ thymi. FACS 
analysis of 3-week control and R26iTbx1/+ thymi showing (A) EpCAM versus CD45. 
Gating on EPCAM+, CD45- TECs analysis of (B) GFP, (C) MHCII, (D) Ly51, and (E) 
CD80 was performed on R26iTbx1/+ thymi versus controls.  
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(unpublished results from Dr. Claire Blackburn’s lab). During fetal development the 
relative number of Plet-1 positive cells does not change. Plet-1+ cells divide 
asymmetrically to self-renew and also give rise to more differentiated progenitors 
that replenish cortical and medullary subsets (unpublished results from Dr. Claire 
Blackburn’s lab). We analyzed the frequency and localization of Plet-1+ TECs in 
adult R26iTbx1/+ thymi to determine if the accumulation of progenitors observed in 
late fetal gestation persisted in the adult. Control thymi at 4wks of age contained 
scattered Plet-1 positive cells throughout the medulla (Figure 15 A, C). A few Plet-1 
progenitors were also localized to outer cortical regions (Figure 15 C, D). In 
contrast, the hypoplastic, disorganized R26iTbx1/+ thymi contained a dramatic 
increase in the frequency of Plet-1 positive cells that localized largely to the outer 
sub-capsular area but could also be found throughout the thymic lobes (Figure 15 
B).  
Surprisingly, many of the Plet-1 positive progenitor cells in R26iTbx1/+ did not 
express detectable GFP. This could be due to 1) the levels of GFP are below the 
threshold of detection 2) silencing of the iTbx1 locus 3) generation from Foxn1 
negative cells that do not activate Cre in this model. In short, these data suggest 
that the accumulation of Plet-1 progenitors observed in fetal R26iTbx1/+ thymi persists 
into adult stages and furthermore aberrantly localize to the cortical sub-capsular 
region.  
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Figure 15. Accumulation of Plet-1 progenitors is maintained in postnatal thymi. (A-
B) Frozen Plet-1 stained sections from 4 wk thymi. Dashed line outlining fetal lobes 
was generated from tracing Dapi stained sections (not shown). (100x) (C-F) Plet-1, 
GFP and Dapi staining of 4wk frozen R26iTbx1/+ thymi (D, F) and controls (C, D) at 
(200x) middle panel or (400x) bottom panel, n = 2 individuals per genotype.
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Thymocyte maturation is impaired in R26iTbx1/+ mice  
Given that thymocyte-TEC crosstalk is essential for proper maturation of 
thymocytes, we analyzed thymocyte subsets in 3-week thymi defined by FACS 
analysis as a read-out of TEC functionality (Figure 16). CD4 and CD8 define the 
major thymocyte subsets, all which were present in R26iTbx1/+ thymi. However, two 
out of three R26iTbx1/+ thymi analyzed had a clear decrease in CD4 and CD8 SP 
thymocytes along with an increase in the percentage of DP thymocytes, relative to 
control thymi (top panel, second and fourth FACS plot) This suggests a partial block 
in the DP to SP stage of maturation. This block is likely a result of a decrease in 
MHCII by TECs, as MHCII expression by TECs is required for normal thymocyte 
maturation. A third individual, (top panel, third FACS plot) contained percentages 
that were more comparable to control thymi. This variability in thymocyte maturation 
may be attributable to the variations observed in TEC differentiation, as described 
earlier. Regardless, the total thymus cellularity observed is consistently reduced.  
We also analyzed the distribution of thymocyte progenitor subsets in the DN 
population that are defined by expression of CD44 and CD25 (Figure 16, bottom 
panel) in order to determine if the reduction observed in overall cellularity could be 
explained by defects in early thymocyte maturation. All R26iTbx1/+ thymi had a DN1 to 
DN2 block as shown by the presence of a population expressing high levels of 
CD44 and intermediate levels of CD25 expression (Figure 16, bottom panel). This 
distinct population is not observed in control thymi. In addition, an increase in the 
percentage of DN4 thymocytes (CD25-, CD44-) and a decrease in DN3 thymocytes 
(CD25+, CD44-) was consistently observed in all three individuals relative to controls  
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Figure 16. Thymocyte maturation is impaired in postnatal R26iTbx1/+ thymi. CD4 
versus CD8 FACS analysis of 3 wk thymi with percentages of each population 
indicated (top panel).  DN thymocytes were further analyzed for CD44 and CD25 
expression (bottom panel).
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(Figure 16, bottom panel). Interestingly, very few DN3 thymocytes were present in 
one of the R26iTbx1/+ thymi. This phenotype was similar to that reported by the 
Manley lab in Foxn1delta/delta mice (82). These mice lack the n-terminal region of 
Foxn1 required specifically for TEC maturation. The observed defects in thymocyte 
maturation are likely to be a secondary consequence of the defects in TEC 
differentiation in R26iTbx1/+ thymi.  
 
Autoimmune manifestations arise in some R26iTbx1/+ individuals 
Given the observed blocks in thymocyte maturation and presumably defects in 
positive and negative selection, we considered whether the R26iTbx1/+ adult mice 
developed autoimmunity. We suspected this may be the case since several of these 
mice had obvious eye defects. Eyes of several R26iTbx1/+ mice had bulging eyes 
abnormally protruding from their skull. In addition, some of these mice also had their 
adjacent eye noticeably sunken into their eye socket.  All of these effected mice 
were lethargic and moribund. Dr. Donna Kusewitz, DVM, Ph.D. necropsied and 
performed an in depth pathological evaluation on two R26iTbx1/+ mice and littermate 
controls. In addition, to thymus hypoplasia both R26iTbx1/+ mice had evidence of 
pathological abnormalities not observed in control littermates (Figure 17). Mild 
keratitis and marked fibroplasia was observed R26iTbx1/+ corneas along with corneal 
conjunctivitis and inflammation of the intraorbital and extraorbital lacrimal glands 
and Meibomian glands of the eyelids (Figure 17 bottom panel, Figure 18). No 
obvious difference in goblet cell number was apparent. Furthermore, mites were 
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Figure 17. R26iTbx1/+ 8 wk mice have hypoplastic thymi and lymphocytic infiltration 
in lacrimal glands of the eye. (Top and bottom panels) H&E stained sections of 
paraffin embedded thymi (top panel) and extraorbital lacrimal glands (bottom panel). 
Arrows indicate lymphoid infiltrates. 
R26+/+, Foxn1 Cre/+ R26iTbx1/+, Foxn1Cre/+
8 wks 8 wks
8 wks 8 wks
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Figure 18. R26iTbx1/+ eyes have inflammatory infiltrates not observed in controls. 
H&E stained corneal sections. R26iTbx1/+ eyes show adhesion of cornea to iris 
(arrow). (Middle left) closer view of cornea iris adhesion in R26iTbx1/+ mouse. (Middle 
right) lymphoid aggregates in conjunctiva of R26iTbx1/+ mouse. (Lower left) 
intraorbital lacrimal gland in R26iTbx1/+ mouse with lymphoid infiltrates.  
 
 8 wks 8 wks
8 wks 8 wks
8 wks
R26iTbx1/+, Foxn1 Cre/+
R26iTbx1/+, Foxn1 Cre/+ R26iTbx1/+, Foxn1 Cre/+
R26iTbx1/+, Foxn1 Cre/+
    R26+/+, Foxn1 Cre/+
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found on the eyelids of R26iTbx1/+ mice but not co-caged littermate controls, 
suggesting the possibility of an immune phenotype present in R26iTbx1/+ mice that  
renders them more susceptible to parasitic infection. Other organs shown to 
develop lymphocytic infiltrates with autoimmunity such as the liver were only mildly  
affected, however this may be due to the age at which they were sacrificed. Older 
mice may have shown more severe autoimmune manifestations. However, mice 
with affected eyes were sacrificed at the noticeable onset of this phenotype and not 
allowed to age for ethical reasons.  
Final reports obtained from the pathology core, concluded that the corneal, 
conjunctival and lacrimal gland lesions found were suggestive of an autoimmune 
phenotype, similar to that reported in Aire-deficient mice and mouse models for the 
immunodeficiency disorder Sjogren syndrome (83, 84). This suggests that 
sustained activation of Tbx1 in TECs impairs the establishment of central tolerance.  
Necropsies performed on 1 yr R26iTbx1/+ (n=2) and control littermates (n=2), did 
not reveal any corneal abnormalities in R26iTbx1/+ mice relative to controls. No 
significant findings were observed in aged-mice of either genotype. However, thymi 
in both R26iTbx1/+ individuals were severely hypoplastic, relative to controls. Although 
control thymi showed thymic degeneration consistent with age-related atrophy, 
R26iTbx1/+ thymi were much smaller with an abnormal breakdown in normal thymic 
architecture. In addition, R26iTbx1/+ thymi also contained cystic regions often lined 
with ciliated epithelium similar to the epithelial lining found in lung (Figure 19). This 
is consistent with cysts that form in the nude mouse (85). Previously investigators 
reported the presence of ciliated cysts in these Foxn1 deficient mice (85). In 
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addition, later reports concluded that the presence of these cysts correlated 
inversely with regions occupied by thymocytes suggesting a different program of 
differentiation that is adopted by these TECs in the absence of thymocytes. 
Although this TEC population was blocked in maturation they were highly 
proliferative and likened to a progenitor-cell type, arising from the medullary 
epithelium. Furthermore, similar to cysts found in R26iTbx1/+ mice, these investigators 
also reported thymic epithelia that lined cysts to be positive for K5. This suggests 
that the cysts formed in iTbx1 expressing mice may be phenotypically similar and 
may also consist of progenitor cells that fail to adopt the proper maturational 
program.  
Together these data demonstrate that defects in TEC maturation and 
consequent aberrant thymocyte differentiation result in autoimmune pathology in 
adult R26iTbx1/+ mice. 
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Figure 19. Ciliated epithelial cysts are found in 1 yr R26iTbx1/+ thymi. (A-B’’) H&E 
stained sections of paraffin embedded 1 yr thymi. (A) control thymus, (B) R26iTbx1/+ 
thymus, both taken at the same magnification. (B,B’’) R26iTbx1/+ thymi containing 
closer views of cysts within the thymus. The arrow indicates an area of respiratory 
epithelium characterized by cilia or secretory product lining a cyst. 
1 yr 1 yr
1 yr
1 yr
R26+/+, Foxn1Cre/+ R26iTbx1/+, Foxn1Cre/+
A B
B’
B’’
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Chapter 2. Perithymic adipose tissue forms in the R26iTbx1/+ postnatal thymus 
Gross examination of adult R26iTbx1/+ thymi in situ revealed an additional striking 
phenotype not observed in age-matched littermate controls. All postnatal mice 
examined, had hypoplastic thymic lobes that were embedded in adipose tissue 
(Figure 20). This thymic phenotype was not observed at any time in the developing 
embryo in controls or R26iTbx1/+ thymi (Figure 21 A) indicating a dynamic 
accumulation or differentiation event occurring just subsequent to birth. Adipose 
tissue in R26iTbx1/+ mice was confirmed using Oil-Red-O staining (Figure 21) and 
preliminarily with Ppar-γ staining (Figure 22 B). Oil-Red-O stains lipid accumulations 
while Ppar-γ is a transcription factor expressed by adipocytes and required for their 
development. The accumulation of adipose tissue was seen largely surrounding the 
exterior of the hypoplastic thymus lobes. However, in thymic sections Oil-Red-O 
and Ppar-γ positive cells were observed throughout the thymic lobes (Figure 21 B 
and Figure 22 B). Furthermore the amount of adipose tissue encasing thymic lobes 
appeared to correlate positively with age, as older R26iTbx1/+ individuals contained 
thymi with the greatest extent of Oil-Red-O staining (Figure 21 B-D). The origin of 
the cells that generate the perithymic adipose tissue is not yet known. However, 
another thymic phenotype in R26iTbx1/+ embryos may shed light on this phenomena.  
During early stages of thymus organogenesis each thymus rudiment is 
surrounded by a NCC-derived capsule. The NCC-derived capsule provides growth 
factors such as such as Fgf-7 and Fgf-10, which are required for expansion of the 
developing epithelium. A well-demarcated NCC-derived capsule was detected 
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Figure 20. Gross examination R26iTbx1/+ thymi in situ reveal perithymic adipose 
tissue. (A) Control mice show prominent thymic lobes localized anterior to the heart. 
(B, C)) Images taken at the same magnification of R26iTbx1/+ thoracic cavities 
showing a hypoplastic thymus encased in adipose tissue. Note location is marked 
by a black box. (B’ and C’) Higher power images of the boxed areas in B and C 
showing perithymic adipose tissue. 
R26+/+, Foxn1Cre/+            
  R26iTbx1/+, Foxn1Cre/+                                
A
B B’
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Figure 21. Adipocytes are not observed in fetal R26iTbx1/+ thymi but accumulate 
progressively with postnatal age. Oil-Red-O staining of R26iTbx1/+ thymi and 
controls at (A) E17.5, (B) NB (200x), (C (40x)) and D (200x)) 4 wks. Note that 
control thymi at E17.5 are taken at 40x, while E17.5 R26iTbx1/+ thymi were captured 
at 100x for viewing purposes. n = at least two thymi per age per genotype. 
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Figure 22. Ppar-γ is up-regulated in fetal stoma and prominent in R26iTbx1/+ 
postnatal thymi. (A) qRT-PCR of Pparγ on E17.5 control and R26iTbx1/+ pooled 
EpCAM-, CD45- stromal cells. (B) Pparγ and Dapi staining of 8 week control and 
R26iTbx1/+ thymi. Both images captured at 200X. 
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surrounding E14.5 control thymi by staining for PDGFRα, a marker of NCC-derived 
mesenchyme (Figure 23 A-B’). At E17.5 staining for PDGFRα revealed a NCC-
derived capsule in controls. In addition, NCCs are present within the thymus 
epithelium at this stage (Figure 23 C-D). The immigration of NCCs into the thymic 
stroma is consistent with reports from other labs,(33), demonstrating that NCCs 
provide structural support for the developing thymic vasculature as they differentiate 
into pericytes. In striking contrast, we observed an expanded, thick PDGFRβ 
capsule surrounding E14.5 and E17.5 in R26iTbx1/+ thymic lobes (Figure 23 B, B’, D, 
See arrows). This capsule appeared to protrude into the thymus lobes creating a 
lobular appearance (Figure 22, B’, D, see arrows). In addition, intense PDGFRβ 
staining was observed in regions that appeared to be pinching off from the thymus 
lobe (Figure 23, D, see arrow). R26iTbx1/+ thymic NCC-derived capsules remained 
prominent even at late stages of gestation (Figure 23 D) and did not decrease in 
thickness with age as observed in E17.5 control thymi (Figure 23 C).   
We analyzed postnatal thymi from 4 wk old mice for the persistence of NCC-
derived mesenchyme and also for development of the thymic vasculature (Figure 
24). Control thymi at 4 wks of age contained PDGFRβ positive cells that lined  
VE-Cadherin positive blood vessels (Figure 24 A, E). This is consistent with 
reported generation of pericytes from NC-derived cells (33). In striking contrast, 
R26iTbx1/+ thymi contained a dramatic increase in PDGFRβ positive cells that were 
dispersed throughout the entire lobe. These cells did not always localize with the 
vasculature (Figure 24 B-D). Staining appeared prominent in areas that appeared to 
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Figure 23. Fetal R26iTbx1/+ thymi are surrounded by a prominent NCC-derived 
capsule. (A-D’) PDGFRα, K5 and Dapi staining of control and R26iTbx1/+ thymic 
sections from E14.5 and E17.5 embryos. (A-B) Control and R26iTbx1/+ E14.5 frozen 
sections (100x) or (A’-B’) (200x). (C-D) E17.5 control and R26iTbx1/+ frozen thymic 
sections stained for PDGFRα and K5 (100x). Arrows denote prominent capsule.   
n = at least 2 individuals per genotype. 
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Figure 24. NCC-derived mesenchyme is aberrantly localized throughout postnatal 
R26iTbx1/+ thymi. 4wk frozen thymi from control or R26iTbx1/+ mice were stained with 
either PDGFRβ and Pancytokeratin (A-D) or VE-Cadherin and K5 (E, F). All images 
captured at 100x. n = 2 individuals per genotype. 
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be budding off from the main lobe (Figure 24 C) and appeared almost invasive in 
nature.  
It is tempting to speculate that postnatal adipose tissue arises from NCC-
derived mesenchyme, given that this expanded capsule in fetal R26iTbx1/+ thymi, 
precedes the appearance of postnatal adipose tissue. Lineage-tracing analyses are 
underway but are not yet completed. The finding of an obvious NCC phenotype in 
R26iTbx1/+ thymi is particularly interestingly since the inducible Tbx1 allele is not 
expressed in NCCs. This NCC phenotype is likely to be an indirect consequence 
attributable to an alteration in the essential crosstalk that occurs between TECs and 
NC-derived mesenchyme that is essential to orchestrate the developmental 
processes that result in thymus organogenesis.  
 
Discussion 
 
In conclusion, these studies support the hypothesis that forced activation of 
Tbx1 in fetal TECs in not permissive for normal thymic development, and instead 
results in severe thymic hypoplasia, aberrant TEC differentiation and an overall 
decrease in thymus output. This is further evidenced by a loss of epithelial 
organization, defective thymocyte maturation, and abnormal NCC-derived 
mesenchymal invasion. In addition this progressive phenotype also coincided with 
an accumulation of postnatal adipose tissue, a feature often associated with 
degenerative thymi.  The arrest of TEC differentiation was evidenced by aberrant 
expression of markers associated with differentiated TECs as well as by an 
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accumulation of Plet-1 positive progenitors in both fetal and adult thymi. Foxn1, a 
master regulator of TEC maturation and thymus homeostasis, was down-regulated 
in fetal TECs, suggesting that Tbx1 expression negatively regulates this essential 
transcription factor.  These defects did not arise secondary to defects in pouch 
formation or pouch patterning, as normal fate boundaries and pouch volume were 
comparable between R26iTbx1/+ and control mice. R26iTbx1/+ thymi consistently had 
an appreciable decrease in overall cellularity and hypoplastic thymi. Individuals that 
were most severely affected developed an autoimmune phenotype that manifested 
in corneal lesions and inflammatory infiltrations. Taken together, the data in this 
dissertation demonstrate that Tbx1 expression must be down-regulated in the 3rd 
PP thymus-fated domain to permit Foxn1 expression, TEC differentiation and 
normal thymus organogenesis and homeostasis.  
 
Tbx1 plays many dynamic roles during development 
 
Tbx1 plays many roles in different tissues during different times in development. 
Although the exact molecular mechanisms attributable to the thymic phenotypes 
observed in R26iTbx1/+ mice are still being elucidated we can glean clues to its 
actions by studying its functions in other tissues and organs, which utilize similar 
developmental pathways to achieve normal organogenesis. We can also analyze 
signaling pathways affected by Tbx1 in other developmental systems. Often the 
developmental roles of these effector molecules are preserved from one structure to 
another and thus the resulting effects of these downstream targets may be 
recapitulated in thymus development.  
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Tbx1 is expressed in cardiac progenitor cells where it regulates their 
proliferation and differentiation (86). These progenitors give rise to the secondary 
heart field and contribute to formation of the outflow tract, atria and right ventricle 
(reviewed in (87)). In this cell population, proliferation is promoted by Tbx1, while 
differentiation is antagonized (86). Therefore loss of Tbx1 expression is associated 
with premature differentiation of these progenitor cells, whereas ectopic expression 
of Tbx1 suppresses differentiation (86). This suggests that Tbx1 must be tightly 
regulated in order to balance the maintenance of a progenitor pool while still 
allowing for formation of more differentiated cell types. Previous studies have shown 
that Tbx1 interacts with Fgf’s to exert some of its downstream effects (68, 88).  
Cardiac defects in Tbx1 heterozygous mice could be partially rescued when 
Fgf8 was ectopically expressed in Tbx1 deficient cells, using a mouse model that 
knocked out Tbx1 by knocking in Fgf8 (89). This partial recue was only observed 
when some expression of Tbx1 was preserved indicating a requirement for Tbx1 for 
an Fgf8 response. This evidence implicates a role for Tbx1 in cardiac 
morphogenesis and also reveals it acts in a linear pathway with Fgf8 (63, 89, 90).  
Consistent with a link between Tbx1 and Fgf8, other investigators reported that 
a Tbx1-Six1/Eya1-Fgf8 pathway is required for normal cardiovascular 
morphogenesis and craniofacial morphogenesis (63). Six1 and Eya1 regulate Fgf8 
in cardiac progenitors to sustain their survival and proliferation and thus regulate 
cardiovascular morphogenesis (63). This pathway is also employed in patterning 
the 3rd PP as discussed earlier (61). Six1-/- mice did not have an altered expression 
pattern of Tbx1 (61, 63). The penetrance of cardiovascular defects observed in 
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Tbx1+/- mice increased almost 3-fold when crossed to mice deficient in Eya1, 
(Tbx1+/-, Eya1+/-). Tbx1+/-, Eya1-/- compound mutants displayed cardiovascular 
phenotypes that were 100% penetrant (63). An increase in penetrance was also 
observed when Tbx1+/- mice were crossed to yield Tbx1+/-, Six1+/- compound 
mutants (63). These data suggest Tbx1 lies upstream of Six1 and Eya1 in a 
common regulatory pathway that mediates Fgf8 signaling.  
Tbx1 also regulates tooth morphogenesis. Tooth morphogenesis is an ideal 
system to study pathways involved in organogenesis, as many inductive 
interactions are required for tooth development. Crosstalk between NCC-derived 
mesenchyme and the oral epithelium is essential, similar to the requirement for 
crosstalk between these two tissues in thymus organogenesis. In short, formation of 
an epithelial bud occurs as the oral epithelium invades into underlying condensing 
mesenchyme. This results in formation of a tooth bud and eventually a “bell” stage 
tooth germ which later forms a tooth as cells within the late bud differentiate into 
ameloblasts that produce enamel and odontoblasts which produce dentin (reviewed 
in (91)). E16.5 Tbx1-/- mice form smaller molars, lack cusps and have only a thin cell 
layer of pre-ameloblast (92). This phenotype is exacerbated at E18.5 as 
homozygous null mice form incisors that lack proliferating epithelial cells (92). Tbx1 
null mice were found to up-regulate the cyclin-dependent kinase inhibitor p21, which 
is normally down-regulated during cell division (92). This increase in p21 expression 
was due to a lack of Tbx1-dependent PITX2 repression (92). PITX2 is a 
transcriptional activator of p21 and is inhibited by binding of Tbx1 to its C-terminal 
domain (92). Although we did not find a significant difference in proliferation 
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between R26iTbx1/+ and control thymi at E17.5, differences in proliferation may occur 
regulation occur at earlier or later developmental ages. For example Tbx1 in TECs 
may maintain a slow-cycling progenitor population, such as Plet-1 positive TECs, by 
negatively regulating cell cycle inhibitors such as p21. Slight changes in proliferation 
at E17.5 may be beyond a detectable threshold but more apparent at later stages of 
maturation that have yet to be thoroughly analyzed in the context of cell division.   
Bmp4 signaling is required for normal thymic development (93, 94). It has also 
been found to regulate development of cardiac progenitors (95) and mediate 
septation of the outflow tract. Recently, micro RNAs (miRNAs) were found in the 5’ 
UTR of certain genes associated with cardiac development, including Tbx1. When 
activated by Bmps these miRNAs suppressed Tbx1 and other genes such as Isl1 
known to be expressed in cardiac progenitors and promote myocardial 
differentiation (96). This evidence implies Bmp’s indirectly negatively regulate Tbx1. 
In thymic development Bmp4 is expressed at E10.5 in the ventral-thymus fated 
domain in the 3rd PP and also in surrounding mesenchyme. Previous reports have 
shown that Bmp4 positively regulates thymus organogenesis by promoting Foxn1 
expression in TECs (93). Furthermore deletion of Bmp4 in the endoderm and 
surrounding mesenchyme prior to Foxn1-expression resulted in morphological 
defects including failure of normal capsule formation and persistent of a thymic 
lumen (97). This suggests that inductive interactions between NCCs and thymic 
epithelial cells are required for proper organ formation. Given that Tbx1 expression 
normally becomes restricted to the anterior dorsal parathyroid fated domain at 
E10.5, in a complimentary expression pattern to Bmp4 and that these signaling 
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components are associated with opposing identities in the 3rd PP, it is possible that 
they may serve as mutually antagonistic regulators of cell fate in the 3rd PP. Forced 
expression of Tbx1 in the ventral thymus fated domain may therefore negatively 
regulate expression of Bmp4 in the endoderm resulting in abnormal thymic 
morphology and a decrease in Foxn1 expression. It is also possible that ectopic 
activation of Tbx1 in the ventral endoderm may result in aberrant signaling 
interactions between the epithelium and surrounding mesenchyme resulting in 
impaired formation of a NCC-derived capsule.   
Coinciding with the notion that they may be acting in a regulatory loop, Tbx1 
has also shown to inhibit the Bmp signaling pathway by sequestering SMAD1 and 
thus preventing its interaction with SMAD4. Binding to the co-factor SMAD4 is 
required for nuclear translocation and transcriptional activation of downstream 
target genes. This binding has been shown to antagonize Bmp signaling and occurs 
independently of the DNA T-box binding domain.  
Tbx1 has been shown to transcriptionally activate Fgf10 in vitro (68). Several 
studies also reported in vivo findings that support this claim in the anterior heart field 
(88, 98). In pancreatic development mesenchymal-epithelial interactions are 
essential and in part mediated by signals from Fgf10 expressed in the mesenchyme 
required for maintenance of epithelial progenitors (99). Furthermore, Fgf10 signaling 
to the pancreatic epithelium acts during a specific developmental window and is 
concentration dependent. Fgf10 null mice display a hypoplastic pancreas, however 
a clear understanding of its role in pancreaganesis was complicated by early 
embryonic lethality of mutant mice (100). To elucidate the role of Fgf10, 
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investigators drove expression ectopically in the pancreatic epithelium where it 
acted in an autocrine fashion and lead to an impairment of pancreatic epithelial 
differentiation (99). Analysis of markers that are used to identify early immature 
progenitors lead to the conclusion that this sustained expression arrested the 
epithelium in a progenitor state (99). 
These examples are not inclusive of the roles played by Tbx1 in development. 
Clearly there are many more, which will not be discussed in the scope of this thesis. 
While several transcriptional effects of Tbx1 are mediated through its T-box binding 
domain, other effects are independent of this DNA-binding domain implying that 
Tbx1 can regulate tissue morphogenesis by utilizing many diverse strategies that 
may be temporally or tissue-specific. 
 
Blocks in TEC differentiation in R26iTbx1/+ thymi coincide with a decrease in 
Foxn1 expression   
Thymic defects in R26iTbx1/+ mice were observed as early as E12.5 since thymic 
rudiments already appeared hypoplastic compared to controls. This phenotype 
appeared progressive with age. Thymic lobes became highly lobulated and 
disorganized in fetal and adult R26iTbx1/+ mice. These defects were not due to 
aberrant pouch formation as the pouch volume of R26iTbx1/+ and R26+/+ 3rd PPs were 
comparable. In addition, thymic defects were not attributable to alterations in 
patterning of the 3rd PP as Foxn1 and Gcm2 fated domains were not affected. 
Expression of GFP, a marker of Tbx1 expression, was detected at E12.5 indicating 
successful Cre-mediated recombination and expression of Tbx1. However this does 
	  	   122	  
not exclude the possibility that Tbx1 may be expressed earlier within the 3rd PP, as 
expression of Foxn1 has been shown to occur at E11.25. Regardless, conditional 
activation of the iTbx1 allele using Foxn1Cre does not appear to alter patterning of 
the 3rd PP with respect to either Foxn1 or Gcm2.  
Blocks in TEC differentiation and a breakdown in normal thymus morphology 
were evident as early as E14.5 in fetal development in R26iTbx1/+ thymi and 
sustained in the adult as evidenced by immunohistochemistry and FACS analysis. 
MHCII expression is expressed by E12.5 in the developing epithelium and is an 
early marker of TEC maturation and functionality. E17.5 R26iTbx1/+ TECs had a 
marked reduction in the expression of MHCII, implicating a block in one of the 
earliest stages of TEC maturation, required for the functional ability to present 
antigen to developing thymocytes. Further blocks of differentiation in R26iTbx1/+ thymi 
were evidenced by a decrease in the number of UEA+ cells, as well as by a 
decrease in the percentage of TECs that express the functional marker CD80. 
Furthermore, there was a variable and altered frequency of TEC subsets defined by 
expression of K5, K8 and K14 and these subsets were severely disorganized such 
that there were often no distinct cortical and medullary regions. This indicates that 
expression of Tbx1 in TECs blocks their maturation and organization.   
Blocks in TEC differentiation may be attributable in part to the reduction of 
Foxn1 levels observed at E17.5 that occur as a result of ectopic sustained activation 
of Tbx1 in TECs. Foxn1 is essential for TEC differentiation and maintenance in a 
dose sensitive manner (47). The Manley lab generated Foxn1lacZ mice by inserting 
an IRES-lacZ cassette into the 3’UTR of the Foxn1 locus (49). Although fetal mice 
	  	   123	  
express lacZ in a manner that recapitulates normal Foxn1 expression, analysis of 
postnatal Foxn1lacZ/lacZ thymi revealed a 50% reduction in Foxn1 mRNA levels 
occurring as early as 1 wk after birth (47). The reduced gene dosage was 
attributable to hypermethylation of the Foxn1 promoter region (47). FoxnlacZ/lacZ mice 
were crossed to Foxn1nu/nu mice, to generate an allelic series for analysis of gene 
dosage effects (47). Down-regulation of Foxn1 resulted in degeneration of the TEC 
compartment, thymic atrophy and a loss of specific TEC subsets. These defects 
directly correlated in severity with Foxn1 levels (47). Foxn1lacZ/lacZ and Foxn1lacZ/nu 
thymi had a decrease in the overall percentage of MHCIIhi TECs and a loss of 
UEA1+ TECs compared to Foxn1+/lacz thymi (47). MHCIIhi UEA1+ mTECs have been 
reported to express the highest levels of Foxn1 mRNA and are therefore most 
sensitive to its reduction, with even slight changes in Foxn1 transcription profoundly 
affecting this mTEC population (47). The phenotype in Foxn1lacZ/lacZ mice is similar 
to that in R26iTbx1/+ thymi, supporting the premise that the reduction in Foxn1 
expression observed in R26iTbx1/+ TECs drives the aberrant TEC differentiation. It is 
interesting that R26iTbx1/+ thymi are able to retain expression of some cortical 
markers, notably Ly51 further coinciding with the notion that mTECs appear to be 
more severely affected and thus more sensitive to a reduction in Foxn1 levels.  
The idea that Tbx1 may antagonize Foxn1 directly has been investigated using 
Transcriptional Regulatory Elements Database (TRED) designed by the Micheal 
Zhang Laboratory at Cold Spring Harbor, which investigates regulatory elements 
upstream of transcriptional start sites for regions complimentary to known 
consensus binding sequences. Although a sequence capable of binding the T-box 
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binding domain was not found, this does not exclude the possibility that these two 
transcription factors directly interact. The Foxn1 promoter region has yet to be 
thoroughly characterized, so a binding site for Tbx1 may exist but has yet to be 
uncovered. It is also possible that Tbx1 antagonizes Foxn1 through a mechanism 
independent of its DNA binding site, as is the nature of its interaction with SMAD1 in 
craniofacial and cardiac development (described above). Lastly this inhibition may 
result indirectly, through interaction with other proteins that subsequently impinge 
upon Foxn1, as has been reported in the dental epithelium where Tbx1 negatively 
regulates p21 by inhibiting its upstream activator Pitx2.   
 
Sustained expression in R26iTbx1/+ TECs results in a progenitor arrest 
The accumulation of Plet-1 positive TECs is suggestive of maturational arrest at 
an early TEC progenitor state. Interestingly at E17.5 but not E14.5 in R26iTbx1/+ thymi 
there was a dramatic retention of Plet-1 positive TECs. At E14.5, prior to this 
observed accumulation, Foxn1 expression levels were comparable between control 
and R26iTbx1/+ thymi. While the frequency of Plet-1 positive TECs decreases with 
developmental age in control thymi, the frequency of Plet-1 progenitors increased in 
R26iTbx1/+ fetal thymi. Moreover, the accumulation of Plet-1+ progenitors was 
sustained in adult R26iTbx1/+ thymi. The onset of Plet-1 accumulation coincided with 
a decrease in Foxn1 expression relative to controls. Co-staining for GFP and Plet-1 
reveal that most Plet-1+ cells do not express Tbx1 suggesting that they do not arise 
as a direct consequence of ectopic Tbx1 activation. Indeed, Foxn1 is not expressed 
until E11.25, after Plet-1 positive cells arise in the thymic epithelium. Furthermore, 
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Foxn1 is not required for the generation of Plet-1+ TEC precursors since Foxn1nu/nu 
mice contain an immature thymic epithelial rudiment that is entirely Plet-1 positive 
(18).  
It is thought that Plet-1 positive TECs replenish the epithelial microenvironment 
by asymmetric division, in which they self-renew and also give rise to another TEC 
that is directed to differentiate and adapt either a cortical or medullary fate 
(unpublished observation from the lab of Dr. Claire Blackburn). However the exact 
molecular mechanisms required for progenitor self-renewal and/or maintenance of 
an undifferentiated progenitor-like state is unknown. It has been observed that an 
age-related decline in the relative frequency of this population occurs with age as 
these progenitors fail to turn-over and self-renew (unpublished data from the 
Blackburn lab). Interestingly this age-progressive decline also correlates with a 
decrease in Foxn1 expression, which is known to occur with age and also coincides 
with thymic involution and a gradual breakdown in the thymic microenvironment (47, 
101). Considering these data I propose a model for the observed Plet-1 phenotype 
in R26iTbx1/+ thymi. 
Given that Plet-1 positive cells accumulate in Foxn1nu/nu mice and fail to 
differentiate it seems possible that Foxn1 expression may be required in a non-cell 
autonomous fashion to drive asymmetric division of Plet-1 progenitors. In this model 
Plet-1 TECs divide into two daughter cells which both express low levels of Plet-1. 
This can be thought of as an intermediate state for each daughter cell, which is 
transient in nature. One progenitor TEC will up-regulate Plet-1 and serve to 
maintain the stem cell reserve that is required for thymic homeostasis, but the 
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second will receive Foxn1-dependent signals from neighboring TECs which will 
instruct it to down-regulate Plet-1 expression and further differentiate into a 
functional TEC. In the event that Foxn1-dependent signals are not seen by these 
Plet-1 positive TECs they can no longer asymmetrically divide. This would lead to a 
failure of normal TEC differentiation to occur. Consequently the thymic 
microenvironment can no longer be replenished. However, if this model holds true, 
Foxn1-independent signals must also play a role in establishment of this progenitor 
phenotype.  
While an age-related decline in the turnover of Plet-1 positive TECs has been 
observed, this decline also coincides with an overall reduction in the percentage of 
Plet-1 positive TECs with age (unpublished data obtained from Blackburn lab), 
suggesting that this age related phenotype results from a failure of some instructive 
signal(s) to maintain the progenitor niche or progenitors themselves. While a 
decrease in Foxn1 has been predicted to result in thymic involution it may not be 
required to sustain Plet-1 positive TECs, as Foxn1nu/nu mice normally form an 
undifferentiated epithelial compartment consisting of Plet1+ cells that are sustained 
and arrested in a progenitor state. Tbx1 plays many roles in development of various 
tissues, but is often associated with sustaining cells in an immature progenitor state 
and inhibits signaling pathways known to promote maturation (86, 92, 102).  
 
Forced expression of Tbx1 in TECs negatively regulates Hes-1 
We have evidence that Tbx1 may be acting through the Notch-mediator Hes1 in 
TECs to oppose differentiation and retain a pool of Plet-1 positive progenitors. 
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Notch signaling has been shown to have many roles in development that are 
context dependent. In hematopoietic stem cells (HSCs) it has been demonstrated to 
regulate proliferation, and self-renewal (reviewed in (103)). For example, activation 
of Notch signaling in cells within the HSC progenitor niche in bone marrow has been 
shown to be required for maintenance of the HSC pool.  In thymic development, 
Notch activation is associated with T-lineage commitment and differentiation of early 
DN thymocytes (reviewed in (8)). In the intestine, and in neural development Notch 
has also been shown to play a role in fate determination (reviewed in (103)). In the 
developing mouse embryo, it has also been shown to be required for maintenance 
of muscle precursor cells (reviewed in (103)). 
Recently Hes1, a major mediator of the Notch signaling pathway has been 
shown to be required in Tbx1 positive cells for proper development of the 
pharyngeal arch arteries and thymus (81). In addition, Hes1 is expressed in both 
cTEC and mTEC lineages (104). This suggests a requirement for bidirectional 
Notch signaling between developing thymocytes and TECs for normal maturation of 
both cell types. However, a cell-autonomous requirement for Notch signaling in TEC 
development has been difficult to ascertain given its promiscuous non-autonomous 
roles in numerous cell types within the thymus. For example, Notch signaling in T- 
and B-cells through its ligand DLL1 is implicated in normal TEC development. 
Therefore, the function of Hes1 and/or the Notch signaling pathway in TECs in 
regards to their maturation has been largely unexplored.  
The downstream Notch target gene Hes1 has been shown to antagonize Notch 
signaling by binding to the Notch DNA-binding partner RBP-Jκ (105). The decrease 
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in Hes1 expression observed at E14.5 may contribute to an interruption of the 
normal pattern of asymmetric cell division of Plet-1 progenitors. It could also play a 
role normally in TECs to drive a program of differentiation. This leads to the 
establishment of a model whereby Notch signaling in TECs is normally initiated to 
sustain an early progenitor pool. This activation leads to transcription of its 
downstream effector molecule Hes1, which acts through a feed back loop to 
antagonize Notch signaling and promote the differentiation of a small subset of TEC 
progenitors in order to replenish the thymic microenvironment. However this  
feed-back loop in our R26iTbx1/+ mouse model is ultimately broken. Tbx1 either 
directly or indirectly antagonizes Hes1 expression in R26iTbx1/+ thymi leading to an 
increase in Notch signaling and thus an accumulation of Plet-1 positive progenitors 
that are unable to differentiate and adopt either a cortical or medullary fate. This 
may result in the resulting aberrant TEC phenotype observed.  Of particular interest 
is the localization of the Plet-1 positive TECs themselves in R26iTbx1/+ thymi, as they 
appear to arise in clusters surrounding GFP positive TECs. This suggests the 
presence of cellular interactions occurring between both cell types. It is tempting to 
speculate that signals from Tbx1-expressing TECs, perhaps Notch, are permissive 
for the persistence of Plet-1 TECs.  
 
CCL25 and IL-7 chemokines are reduced in R26iTbx1/+ TECs   
Given the reduced Foxn1 expression and the early block in TEC differentiation 
we analyzed expression of genes involved in thymocyte-TEC interactions that may 
be affected and contribute to the defects observed in R26iTbx1/+ thymi. CCL25 is 
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expressed by fetal TECs via Foxn1-independent and –dependent mechanisms (28) 
Although neither an increase in apoptosis or a decrease in proliferation was 
observed in fetal thymi to account for the dramatic decrease in total cellularity, a 
decrease in the TEC-expressed chemokine CCL25 was observed. This ligand is 
secreted by the developing primordium as well as by the more mature thymic 
epithelium later in gestation to attract thymus-seeding cells. CCL25 acts to support 
thymus colonization by binding to chemokine receptor CCR9 expressed on early 
hematopoietic progenitors (28). Mice deficient in CCR9 have a decrease in thymus 
cellularity that is attributable to defects in progenitor homing to the fetal thymus (28). 
This is also one of the developmental defects associated with TECs in Foxn1nu/nu 
mice and results in their inability to attract hematopoietic progenitors. The decrease 
in CCL25 observed may occur as a secondary consequence attributable to a 
reduction in Foxn1 or it may also be the result of other signaling aberrancies. In 
addition it many be that Tbx1 directly antagonizes expression of CCL25. 
Regardless, this decrease in CCL25 expression could result in a decrease in the 
number of progenitors that initially colonize the fetal thymus and subsequently a 
decrease in cellularity.  
Defective TEC differentiation is also evidenced by a decrease in IL-7 at E17.5. 
This decrease consequently results in a failure of early thymic progenitors to be 
sustained in R26iTbx1/+ thymi, likely resulting in defects in early DN maturation 
observed. Defects in proliferation were not observed at this age, but may not be 
apparent, or are too subtle to detect. These subtle defects may later be 
compounded upon by a further collapse of the thymic microenvironment. In addition, 
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these defects may also precede or coincide with a failure of these early thymocytes 
to be sustained in epithelial niches that provide signals required for their 
development. 
Thymocyte maturation in R26iTbx1/+ thymi was reflective of a severely impaired 
thymic epithelium. These defects are directly attributable to the above described 
functional blocks in TEC differentiation, as crosstalk between the thymic epithelium 
and developing thymocytes is essential for T-cell maturation. All of the major 
subsets as defined by CD4 and CD8 were present in R26iTbx1/+ thymi although some 
adult individuals contained diminished CD4+ and CD8+ populations consistent with a 
DP to SP block, while others contained subsets with percentages that were 
comparable to controls. This is likely attributable to variation in expression of MHC II 
within R26iTbx1/+ thymus, with some individuals or lobes being more severely 
impaired. The overall cellularity was consistently drastically reduced in R26iTbx1/+ 
thymi compared to controls. This is likely attributable to defects in the earliest 
stages of thymocyte maturation. In examining DN subsets characterized by 
expression of CD44 and CD25 we consistently found R26iTbx1/+ thymi to contain an 
intermediate population that was CD25hiCD44mid, suggesting a partial DN1 to DN2 
block. In addition we also observed aberrancies that correlated with the DN3 and 
DN4 stages of maturation. A decrease in DN3 was often found to occur in R26iTbx1/+ 
thymi as well as a decrease in DN4. This thymocyte phenotype is reminiscent of 
that reported in Foxn1lacz/lacz mice by the Manley lab (47). This thymocyte phenotype 
is consistent with and likely attributable to the decrease in Foxn1 observed in 
R26iTbx1/+ thymi. 
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Development of a functional thymic epithelium is required for formation of a 
self-restricted, self-tolerant T-cell repertoire and therefore also essential in 
mediating central tolerance. Severe pathological lesions indicative of autoimmune 
manifestations were found by Dr. Donna Kusewit in R26iTbx1/+ mice but not age-
matched, littermate controls. In addition to severe thymus hypoplasia, fibroplasia of 
the cornea, mild keratiitis, conjunctivitis and inflammation of both the intra- and 
extra- orbital lacrimal and Meibomian glands of the eyes were noted. These findings 
are consistent with autoimmune keratoconjunctivits. This pathological lymphocytic 
infiltration is similar to lesions described in Aire-deficient mice (83) and other 
immunodeficient models, such as those mimicking Sjogren syndrome (84). This is 
further evidence of immune failure that is a consequence of a dysfunctional thymic 
epithelium.  
 
Potential sources of postnatal adipose tissue 
The perithymic adipose observed in postnatal R26iTbx1/+ but not controls or in 
fetal thymi of either genotype is intriguing. Thymic adipose is a feature associated 
with involution and its accumulation is correlated with a loss of healthy thymic 
stromal tissue (reviewed in (106)). The molecular mechanisms responsible for this 
age-related involution are unknown, but a decrease in Foxn1 has been found to 
contribute to this degeneration.  While we do observe perithymic adipose that 
increases with postnatal age in R26iTbx/+ mice, we do not believe this model to mimic 
an accelerated form of thymic involution and thus is not a model for age-related 
thymic atrophy. The thymic epithelium in R26iTbx1/+ mice fails to differentiate and 
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develop early on and thus a functional microenvironment is never achieved. 
However, the cellular origin of perithymic adipose tissue is still unknown.  
Given that this phenotype was apparent only after birth, we speculated that a 
possible rapid accumulation of adipocytes around the thymus during late stages of 
fetal gestation may occur, and result in the observed postnatal phenotype. However 
evidence for this theory was not found as Oil-Red-O staining in late fetal gestation 
was negative. This is also consistent with the thymic adipose tissue observed being 
morphologically similar to white adipose tissue, which is generated predominately 
after birth (107).  
We therefore made three hypotheses as to cellular origins of surrounding 
perithymic adipose. Thymic adipose in R26iTbx1/+ mice arises from 1. An epithelial to 
mesenchymal cell transition (EMT) in which TECs adopt a mesenchymal fate, 
subsequent to their differentiation down an adipocyte lineage 2. A transition of 
NCCs into an adipocytes lineage or 3. Differentiation of non-NCC derived 
mesodermal mesenchyme into adipocytes.  
First, we considered the possibility that the perithymic adipocyte accumulation 
could result from an epithelial-to-mesenchymal transition (EMT). This mechanism 
has been postulated to account for generation of thymic adipose tissue that results 
with involution (108). An increase in intrathymic adipose tissue correlates with an 
age-related decline of the orexigen ghrelin and its receptors in TECs (108). A 
deficiency in ghrelin-receptor signaling was also shown to facilitate an EMT 
transition in TECs as evidenced by an increase in the EMT associated marker  
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FSP-1, and lineage tracing analysis (108). These mesenchymal cells were found to 
up-regulate and express a number of pro-adipogenic markers such as PPARγ-2 and 
CD36 and contribute to age-associated thymic adipose tissue. Furthermore, ghrelin 
supplementation in old mice was shown to partially reverse this age-associated 
phenotype (108). We therefore explored the possibility that the increase in thymic 
adiposity observed in postnatal R26iTbx1/+ mice may be a result of an EMT transition 
and subsequent adoption of an adipocyte fate. However we did not find this to be 
the case. Thymic adipose in R26iTbx1/+ mice was found to be GFP negative, 
demonstrating that this tissue was not epithelial in origin. 
We next speculated that perithymic thymic adipose tissue arising in R26iTbx1/+ 
thymi results from either a transition of NCCs or non-NCC derived mesenchyme, 
mesodermal mesenchyme, into an adipocyte fate. Mesodermal mesenchyme has 
been shown to give rise to adipose tissue (109). In addition, in vitro experiments 
using both cephalic and truck NCCs from quail have shown that they can also 
differentiate into adipocytes when cultured under appropriate conditions that include 
retinoic acid (RA)(109). This suggests that these cells retain adipogenic potential. 
Furthermore, when Sox10Cre, R26YFP mice were utilized to trace NCCs and their 
progeny it was found that a subset of adipocytes in the postnatal mouse arose from 
NCCs and not mesoderm (109). This led us to speculate that perithymic adipose 
arise from cells of either NCC or non-NCC derived mesenchymal origin.  
It is interesting that the NCC-derived capsule surrounding R26iTbx1/+ fetal thymi 
is increased in size relative to controls. The prominent NCC-derived capsule is 
maintained even at developmental stages where control NCC-derived capsules 
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decrease in prominence. In addition, NCC-derived mesenchymal were also in areas 
that appear to be budding off from the main lobe, suggesting that this phenotype 
may be invasive in nature. Tbx1 expression has been shown to regulate NCC-
migration in the pharyngeal arch arteries through regulation of the transcription 
factor Gbx2 and aberrancies in this NCC migration pattern have also been observed 
in Tbx1-null mice suggesting a requirement for Tbx1 in proper NCC migration (110).  
It is possible that ectopic Tbx1 signaling from TECs lead to NCC migration pattern 
that promotes their accumulation in the R26iTbx1/+ perithymic capsule. Deficiencies 
or alterations in normal signaling pathways such as Gbx2 from the thymic 
epithelium to adjacent mesenchyme could result in a NCC-phenotype.  
Migration of NCCs into the thymic epithelium occurs normally in development at 
approximately E14.5 as they differentiate into pericytes, which play a supportive role 
in establishing and maintaining the thymic vasculature. Intrathymic NCC derivatives 
were observed in R26iTbx1/+ mice, however only some of these derivates, which 
stained positive by PDGFRα, appeared to coincide with vascular regions as defined 
by VE-Cadherin staining. The functionality of these cells is not known and was not 
assessed. An accumulation in the subcapsular region clearly does not result from a 
failure of these NCCs to migrate into the epithelium, however an impairment in TEC 
differentiation may occur prior to entry into the thymic lobes.  
Given that a prominent NCC-capsule is formed early in development and 
sustained in R26iTbx1/+ thymi and given the preliminary increase of Pparγ observed in 
R26iTbx1/+ stroma, we propose that the thymic adipose tissue observed in postnatal 
R26iTbx1/+ thymi is of NCC origin. To test this assumption we are conducting lineage-
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tracing analysis, using a NCC-specific Wnt-1Flp mouse model. Since, activation of 
the iTbx1 allele in R26iTbx1/+ mice utilizes the cre-lox system to achieve tissue-
specific activation of Tbx1 in TECs, we cannot use Wnt-1Cre mice to indelibly label 
NCCs and their progeny, as this would result in Tbx1 activation in NCCs. Therefore 
we obtained Wnt-1Flp mice from Dr. Susan Dymecki, to take advantage of the FLP-
FRT recombination system instead. These mice will be crossed to a dual reporter 
line, also obtained and generated in the Dymecki lab, in which both GFP and 
mCherry have been knocked into the Rosa26 locus, under the control of a CAG 
promoter, denoted R26Frepe In this model a FRT flanked stop cassette is upstream 
of an mCherry cassette, allowing for expression of the red mCherry protein upon 
Flp-mediated recombination.  
We are currently crossing Wnt-1Flp, R26Frepe lines to R26iTbx1/+, Foxn1Cre/+ lines 
to achieve a Wnt-1Flp, R26Frepe, R26iTbx1, Foxn1Cre expressing mouse. Given the 
elaborate nature of this cross, it has taken considerable time to generate the mice 
required for this experiment. Studies are currently underway to verify fidelity of 
expression of Wnt1Flp, R26Frepe reporter lines. Once confirmed, this line, Wnt1Flp, 
R26Frepe  will be crossed to our R26iTbx1, Foxn1Cre model and allow for either the 
exclusion or confirmation of a NCC-origin for perithymic adipose tissue. NCCs and 
their progeny would express mCherry. Therefore, if the perithymic adipocytes are 
derived from NCCs they will express the mCherry reporter and be red in color. It is 
possible that thymic adipose tissue will not express  mCherry when lineage tracing 
is performed, indicating that these cells are not NCC-derived. A non-NCC derived 
mesodermal mesenchymal origin will then be implied. 
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Conclusions 
Taken together Tbx1 expression in the ventral thymus-fated domain must be 
down-regulated for normal thymus organogenesis to occur and differentiation of the 
thymic epithelium to proceed. Reciprocal interactions between TECs, thymocytes 
and NCC-derived mesenchyme are mutually required for maturation of each cell 
type (Figure 25). Therefore, altered signaling events resulting in developmental 
blocks in one cell population have indirect but significant consequences for another.  
This data suggest a model for thymus organogenesis in which a Plet-1 positive 
progenitor is established initially independent of Foxn1 expression in the epithelium 
and gives rise to more differentiated cTEC and mTEC progenitors through 
asymmetric cell division (Figure 25). This differentiation coincides with a decrease in 
Plet-1 in normal thymi. However, in the R26iTbx1/+ thymus there is an accumulation 
of Plet-1 TECs. Maturation of precursors into functional TECs is blocked, as they fail 
to properly express MHCII and IL-7 required for thymocyte maturation and CCL25 
required for attraction of early thymocyte seeding cells. Furthermore, the mTEC 
specific marker CD80 is markedly decreased suggesting an inability of iTbx1 TECs 
to negatively select for and eliminate auto-reactive thymocytes. These defects are 
likely attributable to a decrease in Foxn1 expression in TECs and consequently 
results in their inability to provide supportive signals required by developing 
thymocytes. Defective thymocyte development thus results indirectly as a 
consequence of aberrant TEC-thymocyte interactions that result from a failure in 
TEC maturation.    
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Although NCCs do not express the iTbx1 allele, we hypothesize that the block 
in TEC differentiation leads to abnormal signaling from TECs to NCCs resulting in a 
NCC-phenotype, initially resulting in an expanded perithymic capsule and later to 
perithymic adipose tissue after birth. Furthermore, a failure of TEC-NCC crosstalk 
could indirectly lead to altered fate decisions in the NCC-derived mesenchyme. 
Taken together, data presented in this dissertation demonstrate that enforced Tbx1-
expression negatively regulates TEC differentiation and Foxn1 expression, which is 
required for TEC development and homeostasis. In addition, the block in TEC 
development prevents the crosstalk among epithelial, hematopoietic and NCCs that 
regulates development of each cell type. Therefore, Tbx1 expression must be 
down-regulated in the ventral thymus-fated domain for mutual inductive interactions 
to be preserved and thymic development to proceed. 
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Figure 25. Model for TEC development in R26iTbx1/+ mouse model. Development of 
a bipotent c/m-TEC progenitor occurs from a founder cell that is Plet1+, Tbx1-, 
Foxn1-. This bipotent progenitor, Plet1-/lo, Tbx1-, Foxn1+ gives rise to more 
differentially restricted TECs and eventually to mature c/m-TECs. In the R26iTbx1/+ 
mouse model the majority of TECs are arrested at the Plet-1 positive stage and fail 
to further mature. These functional defects have indirect but significant affects on 
NCCs and thymocytes, which each mutually rely upon each other for inductive 
interactions for their development. 
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